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ABSTRACT
ACCURACY OF PEDOMETERS AND THEIR USE IN A
10,000 STEPS PER DAY INTERVENTION STUDY
This dissertation was designed to assess pedometer accuracy under both
controlled and free-living conditions and to assess the efficacy and feasibility of the
10,000 steps per day exercise prescription in sedentary, overweight men vs. women. The
specific aims were to 1) assess the accuracy of 10 electronic pedometers over the course
of a 400-m walk; 2) compare the step values of multiple brands of pedometers over a
24-hour period; 3) compare the effects on body composition, cardiovascular risk factors
and adherence in response to a 10,000 steps per day exercise prescription in overweight
men vs. women.
First, the accuracy and reliability of 10 electronic pedometers was assessed over
the course of a 400-m walk. Ten males and 10 females ranging in body mass index
(BMI) from 19.8 to 33.6 kg·m·2 walked 400-m around an outdoor track while wearing
two pedometers of the same model (one on the right and left sides of the body) for each
of ten models. Four pedometers of each model were assessed in this fashion. The Kenz
Lifecorder (KZ), New Lifestyles NL-2000 (NL), and the Yamax Digi-Walker SW-701
(DW) were the most accurate in counting steps, displaying values that were within ±3%
of the actual steps taken, 95% of the time. The Sportline 330 (SL330) and Omron HJ105 (OM) were the least accurate, displaying values that were within ±37% of the actual
steps, 95% of the time. The reliability within a single model (Chronbach's alpha) was
>0.80 for all pedometers with the exception of the SL330. The intra-model reliability
was exceptionally high (>0.99) in the KZ, OM, NL, and the DW.
lll

Second, a comparison of 13 pedometer models was made over a 24-hour period.
Ten males and ten females ranging in BMI from 19.8 to 35.4 kg·m·2 wore two pedometers
for a 24-hour period. The criterion pedometer Yamax Digi-Walker SW-200 (YX200)
was worn on the left side of the body and a comparison pedometer was worn on the right.
Steps counted by each device were recorded at the end of the day for each of the thirteen
pedometers. Subjects took an average of 9,244 steps·d- 1• The KZ, YX200, NL, Yamax
Digi-Walker SW-701 (YX701), and SL330 yielded mean values that were not
significantly different from the criterion. The Freestyle Pacer Pro (FR), Accusplit
Alliance 1510 (AC), Yamax Skeletone EM-180 (SK), Colorado on the Move (CO), and
Sportline 345 (SL345) significantly underestimated steps (P<0.05) and the Walk4Life LS
2525 (WL), OM, and Oregon Scientific PE316CA (OR) significantly overestimated steps
(P<0.05) when compared to the criterion. In addition, some pedometers underestimated
by 25% while others overestimated by 45%.
Third, a comparison of the effects on body composition, cardiovascular risk
factors and adherence was made in response to a 10,000 steps per day exercise
prescription in sedentary, overweight males vs. females. Fifteen men (46 ± 7 yrs) (mean

± SD) and twenty-four women (48 ± 5 yrs) who were overweight or obese participated in
a 10,000 steps per day intervention for 36 weeks. Body weight, BMI, percent body fat,
fat mass, fat-free mass, waist circumference, hip circumference, systolic blood pressure,
diastolic blood pressure, and heart rate were determined at baseline, after 20 weeks and
again after 36 weeks. A blood lipid profile was assessed at baseline and after 36 weeks.
Men and women given a 10,000 steps per day exercise prescription experienced similarly
significant improvements in body weight, BMI, percent body fat, fat mass, waist and hip
iv

circumferences, and HDL-C. When men and women were combined to explore the
effect of adherence to the exercise prescription, the adherers significantly reduced body
weight, BMI, percent body fat, fat mass, waist circumference, and hip circumference
after 36 weeks while the non-adherers experienced little or no change in these variables.
Thus, the 10,000 steps per day exercise prescription was effective at increasing daily
walking volume which resulted in significant improvements in body weight and. body
composition in overweight, sedentary, middle-aged men and women.
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PART I

INTRODUCTION

1

Numerous prospective epidemiological studies support the belief that a physically
active lifestyle is associated with positive health related outcomes. Several studies
confirm the beneficial impact that physical activity can have on a variety of health
conditions including cardiovascular disease, hypertension, obesity, type 2 diabetes,
osteoporosis, and certain types of cancers (2). Despite the large body of evidence
supporting the multiple benefits of physical activity, most Americans are either inactive
or insufficiently active. According to the 1996 Surgeon General's Report, 60% of U.S.
adults do not engage in regular leisure-time activity and about 25% report no leisure-time
physical activity (35). More recently, the Behavioral Risk Factor Surveillance System
(BRFSS) indicated that approximately 55% of American adults are not sufficiently active
to achieve health benefits (5). Healthy People 2010 has placed physical activity among
its leading health indicators which reflect the major public health concerns of the United
States and were chosen based on their ability to motivate action, the availability of data to
measure their progress, and their relevance as broad public health issues .(3 7). Two of the
14 physical activity and fitness goals of Healthy People 2010 are to reduce the proportion
of adults who engage irt no leisure-time physical activity and to increase the proportion of
adults who are regularly active (3 7).
The most recent physical activity recommendations have shifted from the
traditional exercise prescription that focused on vigorous intensity activity for the
attainment of cardiorespiratory benefits to one of moderate intensity activity that has been
shown to improve health outcomes. Evidence from prospective studies in the early
1990's showed that physical activity of lower intensity, duration, and frequency than
required to improve cardiorespiratory fitness could produce significant improvements in
2

health outcomes. The current recommendation issued by the American College of Sports
Medicine (ACSM) and the Centers for Disease Control and Prevention (CDC) in 1995,
encourages American adults to accumulate at least 30 minutes of moderate-intensity
physical activity on most, if not all days of the week (24). It was thought that a
recommendation that allowed for the accumulation of moderate intensity physical activity
through lifestyle activities may decrease the proportion of sedentary adults in the United
States.
As an alternative to the current ACSM/CDC physical activity recommendation,
Dr. Hatano of Japan believes that taking 10,000 steps per day is the amount of physical
activity needed for cardiovascular disease prevention (12). Hatano has found that
increased ambulatory activity is associated with lower levels of blood pressure and
subcutaneous fat (11). Hatano estimated that a 60 kg Japanese male would expend at
least 333 kcal in walking 10,000 steps (12). Previous research indicates that this amount
(>2000 kcals/wk) appears to be protective against heart attacks (23). In addition,
longitudinal studies have demonstrated that walking 10,000 steps per day results in
improvements in cardiovascular disease risk factors in sedentary, at-risk populations (20,
31). This particular physical activity recommendation has been rather highly publicized
in popular periodicals (13, 26).
Physical activity can be viewed as a complex interaction between frequency,
intensity, type and duration, which make it difficult to accurately measure. Thus,
physical activity assessment has been a challenge for researchers attempting to accurately
and objectively quantify this multifaceted behavior. Current methods for assessing
physical activity include questionnaires, doubly labeled water, heart rate monitors, and
3

motion sensors. It is well documented that each method has its own advantages and
limitations (4, 34, 38).
Of the several methods that exist regarding physical activity assessment, motion
sensors, which include accelerometers and pedometers, have some distinct advantages in
regard to the objective measurement of physical activity. Accelerometers have the ability
to monitor and store the actual magnitude of acceleration and deceleration of motion.
However, although accelerometers provide a direct measure of physical activity, they are
quite expensive and often do not provide the user with instant feedback. Pedometers are
an additional type of motion sensor that have the benefit of being low in cost, unobtrusive
to the subject, accurate for ambulatory activity (4, 7), and their output (steps or distance)
is easily comprehendible. Although the early mechanical pedometers were once deemed
unacceptable for physical activity assessment in research studies, the electronic
pedometer has been shown to be accurate under various conditions (4). Despite the fact
that pedometers are limited to the assessment of ambulatory activity, they have been used
in a variety of studies, both interventional and cross-sectional in nature (20, 31-33). In
addition to the abovementioned benefits of pedometers, they also have the potential to
serve as a motivational tool providing immediate feedback to the user. Several electronic
pedometers have been shown to be accurate in measuring distance walked as well as
steps taken at various walking speeds (4, 7).
Physical inactivity is one factor that has contributed to the obesity epidemic.
Overweight and obesity are also among the leading health indicators of Healthy People
2010.- In 2001, the U.S. Surgeon General issued a call to action, that focused on
decreasing the growing epidemic of overweight and obesity that is currently affecting the
4

health of our nation (36). Recent evidence from the National Health and Nutrition
Examination Survey (NHANES) indicates that the prevalence of overweight and obesity
among U.S. adults is 64.5 and 30.5%, respectively (10). Compared with data from
NHANES III (1988- 1994), NHANES (1999-2000) data show that increases in the
prevalence of overweight and obesity have been observed among males and females and
across all ages and racial/ethnic groups (I 0). In fact, it has been estimated that by the
year 2008, nearly 39% of the population will be considered obese (15).
Epidemiological studies show that overweight ( defined for adults as a body mass
index between 25.0 and 29.9 kg/m2 ) and obesity (body mass index 30 kg/m2 or above)
are associated with increases in early mortality in addition to an increased risk for
coronary heart disease, type 2 diabetes, certain types of cancers, and various
musculoskeletal disorders (2 1 ). An estimated 300,000 deaths per year ( I ) and direct
annual health care costs of approximately 70 billion dollars (6) may be attributable to
obesity. In 200 1, the Rand Institute reported that obese individuals have more overall
health problems than smokers or drinkers (30). Currently, it appears that the obesity
epidemic is progressing much faster than our understanding of the etiology of obesity and
our ability to prevent and treat the disease ( 14).
Research suggests that even modest reductions in body weight of 5-10% will
significantly improve health and thus, the achievement of an optimal body weight is not
necessary for some health benefits to be realized ( 16). It is well known that an energy
imbalance, generally considered to be a prerequisite for weight loss to occur, can be
created by reducing energy intake and/or increasing energy expenditure. Several studies
provide evidence to support the beneficial effects of reducing caloric intake on weight
5

loss over the short-term (19, 28). However, an increase in energy expenditure appears to
be an important component of long-term weight loss and/or weight maintenance (19, 28).
Several interventional studies have demonstrated that an energy imbalance created solely
by an increase in energy expenditure can result in a significant amount of weight loss (17,
18, 25, 27-29).
Although exercise has been shown to be an effective tool for weight management,
its effects may be influenced by gender. A meta-analysis of 40 studies by Ballar and
Keesey (3) provided evidence that males lost more body mass than females in response to
run/walk exercise interventions. Additional studies that have examined the impact that
similar exercise programs can have on body composition in males and females (17, 29, 9)
have shown that men respond more favorably than women in regard to body weight
changes. Interestingly, this gender effect on weight loss has also been supported in
studies using male and female rats (8, 22).
In 2001, the ACSM issued a Position Stand (16) that offered strategies for weight
loss and the prevention of weight regain. It was suggested that for long-term weight loss,
overweight and obese adults should eventually progress to 200-300 minwk· 1 of leisure
time physical activity. If for example, a 30-minute walk added to a sedentary
individual's normal daily walking is necessary for them to meet the 10,000 steps per day
recommendation (39), a full week of walking this amount would require a minimum of
210 minwk· 1 , which is consistent with the aforementioned guidelines issued by the
ACSM for weight loss. Although the effects of the 10,000 steps per day recommendation
on various cardiovascular risk factors has been assessed, no studies have compared its
feasibility and efficacy in sedentary, overweight men vs. women.
6

Statement of the Problem

Although electronic pedometers have been validated in a 1996 publication (4),
many newer models have emerged on the market since then. Therefore, it necessary to
determine which of these new models are most accurate under both controlled and free
living conditions. Also, a popular pedometer based recommendation encourages
individuals to accumulate 10,000 steps on a daily basis. However, few studies have
examined the efficacy and feasibility of this recommendation as it pertains to improving
health outcomes, and none have compared the responses of sedentary, overweight males
vs. females to this recommendation.

Statement of Purpose

The purpose of this dissertation is to examine the accuracy of various pedometers
under controlled and free-living conditions and to use one of these devices in an
intervention aimed at comparing the adherence and cardiovascular risk factor responses
of overweight men vs. women to the 10,000 steps per day recommendation. First, Part
III determines the accuracy and reliability of 10 electronic pedometers over the course of
a 400-m walk at a self-selected pace. Second, Part IV compares 13 different pedometers
to a previously validated criterion over a 24-hour period. Finally, Part V compares the
effects on cardiovascular risk factors and adherence in response to a 10,000 steps per day
recommendation in overweight males vs. females.

7

Significance of these Studies
The electronic pedometer is a device that has been previously shown to be
accurate under a variety of conditions. However, since 1 996, no study has been done to
assess accuracy and reliability of these devices. Therefore, it would be of significant
benefit to the scientific community to validate the newest models of these devices under
both controlled and free-living conditions.
With the continued publicity of the 1 0,000 steps per day recommendation, it
would also be valuable to assess both the feasibility and the efficacy of this
recommendation, particularly as it pertains to body weight, body composition, and
cardiovascular risk factors in overweight men and women. It would be especially
interesting to compare the health related changes of males and females in response to this
popular recommendation.

8
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PART II

REVIEW OF THE LITERATURE
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Physical Activity on Health
The benefits of physical activity are well established. Several epidemiological
and interventional studies have served to quantify the numerous health benefits
associated with leading a physically active lifestyle. Some of these benefits include but
are not limited to a decreased risk of cardiovascular disease (6 1, 7 1, 109) and all-cause
mortality (65 , 84) along with lower incidence rates for hypertension, obesity, type 2
diabetes, osteoporosis, anxiety, depression and certain types of cancers (2). A review of
the physiological, epidemiological, and clinical evidence suggests that regular, moderate
intensity physical activity can result in substantial health benefits (87). In addition, it has
been found that even a slight increase in fitness, a byproduct of increased physical
activity, can significantly reduce the relative risk of death from all causes ( 14).

Physical Activity Assessment
Despite the abundance of literature supporting the health benefits of leading a
physically active lifestyle, our ability to accurately measure this multi-faceted behavior
remains a challenge. Currently, various subjective and objective methods exist for
quantifying physical activity. Physical activity questionnaires/interviews, physical
activity diaries, and physical activity recall are among the most common subjective
methods. Although these forms of physical activity assessment are easy to administer,
inexpensive, and noninvasive, they are limited in their ability to assess ubiquitous,
unstructured physical activity (1, 9 1). Objective measures of physical activity focus
principally on body motion or physiological responses to exercise. Heart rate monitors,
doubly labeled water, indirect calorimeters and motion sensors are some of the more
15

common means for objectively assessing physical activity. Pedometers and
accelerometers are the two predominant forms of motions sensors. Accelerometers are
relatively expensive devices designed to quantify vertical acceleration and deceleration of
the body and the output is often in the form of activity counts accessible by downloading
the data. Although accelerometers can estimate with some degree of accuracy, energy
expended in various activities, these devices are limited in their ability to estimate energy
expenditure during activities such as lifting or carrying objects, walking up a grade, or
. climbing stairs. In these activities involving upper body movement, load carrying or
changes in surface or terrain, accelerometers tend to underestimate energy expenditure (9,
39, 120). Pedometers are also limited in their ability to estimate energy expenditure
during non-ambulatory activity. However, these devices are much less expensive than
accelerometers, provide the user with constant feedback on steps taken and are effective
in measuring steps and calculating distance walked (8, 10).

Pedometers
The pedometer is a device designed to measure steps and estimate distance
walked while walking or running (129). Although pedometers were originally used for
surveying land and measuring walking distance (10), it wasn't until the 1960's that these
devices became increasingly popular for researchers interested in assessing habitual
physical activity (115). However, these early mechanical pedometers were found to be
unacceptable for the precision needed for research purposes primarily due to the fact that
they were invalid and unreliable (33, 56, 129). Gayle (33) found that the validity of these
devices varied significantly at speeds ranging from 54 to 107 m-min· 1 and that individual
16

calibrations were needed in order for mechanical pedometers to accurately measure
distance walked. Likewise, Kemper and Vershuur (56) found two types of mechanical
pedometers (one German and one Russian) to be invalid at various walking and running
speeds in adolescent boys.
Although the earlier, mechanical pedometers were deemed unacceptable for
research purposes, the electronic pedometer developed around 1990, offered some hope
for these devices in assessing ambulatory activity. In 1996, Bassett et al. (8) tested five
brands of electronic pedometers and found one model (Yamax DW-500) to have a high
degree of accuracy and reliability. Pedometers were tested for accuracy over a 4 .88 km
sidewalk course_o and at varying treadmill speeds of 54, 67, 80, 94, and 107 mmin· 1 •
There were significant differences in distance walked between the five pedometers over
the 4.88 km course, with the Yamax DW-500 being one of the three most accurate
pedometers at estimating distance. In addition, the Y amax was very consistent in
counting steps when comparing the same model worn on both the right and left sides of
the body. In comparing steps taken at varying treadmill speeds, it was found that the
Yamax DW-500 was significantly more accurate than any of the models for counting
steps and estimating distance, particularly at speeds :S 80 mmin· 1 • Le Masurier et al. (63)
also found the Y amax brand pedometer to be the most accurate of three models assessed
under-controlled and free-living conditions. In this study, the Yamax SW-200, Omron
HJ- 105, Sportline 330 and CSA accelerometer were all compared while walking on the
treadmill at speeds ranging from 54 to 107 mmin· 1 and over a 24-hour period. Of the
three pedometers tested, the Yamax SW-200 demonstrated the lowest absolute percent
error at treadmill speeds '?:_67 m·min· 1 and over 24-hours of free-living.
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In 2003, Le Masurier and Tudor-Locke (64) compared pedometer and
accelerometer accuracy at varying treadmill speeds and while traveling in a motorized
vehicle. It was found that the Yamax SW-200 counted significantly fewer steps than the
CSA (Computer Science Applications) accelerometer (75% vs. 99% of actual steps
taken) at the slowest walking speed (54 m·min- 1 ) but the devices were similar at speeds
?,.67 mmin· 1 • In addition, while the CSA accelerometer counted significantly more steps
at the slowest walking speeds, this device also detected more erroneous steps during
motorized vehicle travel. Although no actual steps were taken during the motorized
vehicle travel, the CSA accelerometer detected 17-fold more erroneous steps than the
Yamax pedometer (p<0.05). Thus, this study suggests that while the Yamax pedometer
has a higher threshold of vertical acceleration required to trigger a step as evidenced by
counting fewer steps at the slowest walking speed, this device is also less likely to detect
erroneous steps during non-ambulatory motion. In addition, while this study showed that
the Yamax pedometer counted just 75% of actual steps taken at 54 m-min· 1 , Hendelman
et al. (39) pointed out that this speed is much slower than a normal walking speed and is
unlikely to be an important source of error in field studies.
Swartz et al. ( 1 19) assessed the effect of body mass index on pedometer accuracy.
In this study, subjects were stratified by body mass index (BMI) into one of three tertiles:
normal (<25 kgm-2), overweight (25-29.9 kg·m-2) and obese (?..,30 kg·m-2). Each
participant walked on a motorized treadmill for 3-minute stages at 54, 67, 80, 94, and 107
m·min· 1 with a Yamax SW-200 brand pedometer placed in each of three locations
(anterior midline of the thigh, mid-axillary line, posterior mid-line of the thigh) on the
belt or waistband. It was found that neither BMI category nor pedometer placement
18

affected pedometer accuracy at any of the five walking speeds. It was also noted that
pedometers were most accurate at walking speeds 2:80 m-min· 1 •
From the aforementioned studies, it can be surmised that electronic pedometers
have promise for use in assessing ambulatory physical activity. Some of these devices
have been shown to be accurate at a variety of walking speeds and among various
populations. In addition, pedometers appear to meet the criteria established by Freedson
et al. (32) to denote an ideal objective instrument in that they are low in cost, easy to
administer to large groups, unobtrusive to the subject, accurate and reliable. Evidence
continues to mount demonstrating that pedometers are practical, accurate and acceptable
tools for the measurement of physical activity (124) and may be the method of choice for
physical activity assessment in epidemiological studies (7).

ACSM/CDC Physical Activity Recommendation

Previous physical activity guidelines from the American College of Sports
Medicine (ACSM) emphasized the importance of vigorous-intensity, continuous aerobic
exercise for the attainment of cardiorespiratory fitness (3). By the early l 990's, scientific
evidence had suggested that physical activity of lower intensity, duration, and frequency
than that required to improve cardiorespiratory fitness could produce significant
improvements in health outcomes. As a result of these findings, the focus of physical
activity guidelines shifted from vigorous- to moderate-intensity exercise. The current
recommendation issued in 1995 by the ACSM and the Centers for Disease Control and
Prevention (CDC) encourages American adults to accumulate at least 30 minutes of
moderate-intensity physical activity on most, if not all days of the week (87). It should
19

be noted that this recommendation is meant to complement, not supersede the previous
recommendation that focused on improving cardiorespiratory fitness.
The current recommendation has several unique aspects that distinguish it from
the previous recommendations. First, the current recommendation emphasizes physical
activity rather than exercise. Physical activity is defined as "any bodily movement
produced by skeletal muscles that results in energy expenditure" ( 15). Conversely,
exercise is a subset of physical activity, defined as "planned, structured, anq repetitive
bodily movement done to improve or maintain one or more components of physical
fitness" (15). Thus, the new recommendation extends the health benefits more generally
to physical activity as opposed to the specific focus on exercise alone. Second, emphasis
has been placed on moderate-intensity physical activity, which is considered to be any
activity performed at an intensity of 3-6 METs, the equivalent of walking 3-4 mph for
most healthy adults. It appears that the majority of the disease prevention benefits can be
gained with moderate-intensity physical activities, which may or may not be part of a
structured exercise routine. Third, the allowance for the accumulation of activity has
been added in the current recommendation. This addition confers the benefits associated ·
with intermittent activity, particularly from an energy expenditure standpoint. As a
result, activities such as gardening, lawn work, and dancing can contribute to the 30minute per day goal as long as the activities are performed at an intensity similar to that
of brisk walking.
A clear goal of this current recommendation to accumulate at least 30 minutes of
moderate-intensity activity on most if not all days of the week was to get more
individuals more active. Thus, an attempt was made to clearly define the minimum
20

amounts and types of physical activities needed to achieve significant health benefits.
However, alternative recommendations have surfaced that have focused on more specific
health outcomes.

Institute of Medicine Recommendation

In 2002, the Institute of Medicine (IOM) suggested that 60 minutes of exercise
per day may be necessary for controlling body weight, a recommendation that is double
that of the ACSM/CDC which focused on the attainment of health benefits. The IOM
recommendation states, "to prevent weight gain as well as to accrue additional, weight
independent health benefits of physical activity, 60 minutes of daily moderate intensity
physical activity is recommended, in addition to the activities required by a sedentary
lifestyle." (47). The IOM recommendation acknowledges that some health benefits can
be achieved by adhering to the ACSM/CDC recommendation, but suggests that this
amount is insufficient to maintain body weight in adults with a BMI ranging from 18.5 to
25 kgm·2 and fully achieve all the identified health benefits. However, the ACSM/CDC
recommendation clearly states that 30 minutes per day, most days of the week is the
minimum amount of activity needed to obtain some health benefits. The ACSM/CDC
recommendation goes on to indicate that the health benefits accrue in approximate
proportion to the total amount of activity, and thus, those who are already meeting the
recommendation will likely reap some additional health and fitness benefits from
becoming more physically active, thereby acknowledging the additional benefits to be
obtained by performing more physical activity than the recommended minimum (87).
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Although the two recommendations are dissimilar in the amount of activity suggested, it
should be emphasized that they were designed with two different goals in mind.

2,000 Steps Per Day Increase

Interestingly, an alternative recommendation that also focuses on the prevention
of weight gain encourages American adults to take an additional 2,000 steps per d�
This translates roughly into an extra 15 minutes of daily walking and was develor
Dr. Hill based on the average annual weight gain of American adults. The Ion,
CARDIA study indicated that the average 15-year weight gain was 22.5 to 3�
among adults between the ages of 18 and 30 years at baseline (68). Thus, ,,

ds
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linear increase in weight over these 15 years, the average weight gain in this population is
about 1.5 to 2.2 pounds per year. Based on this information along with the consideration
of the efficiency of energy storage in humans, Dr. Hill believes that weight gain could be
eliminated by some combination of increasing energy expenditure and decreasing energy
intake by 100 kcal·d- 1 (43). Hill notes that energy expenditure can be increased by 100
kcal·d- 1 by walking an extra mile per day. He states that "Walking a mile, whether done
all at once or divided up across the day, bums about 100 kcal, which would theoretically
completely abolish the energy gap and hence weight gain for most of the population. A
mile of walking for most people is only about 2,000 to 2,500 extra steps, and these steps
could be accumulated throughout the day as life-style activities, for example, taking the
stairs, parking a little farther from a destination, conducting a walking meeting" (43).
Based on the above rationale, Hill has prompted the promotion of an activity
recommendation called "America on the Move" that uses pedometers to motivate people
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to walk an additional 2,000 steps per day. However, at this point, there is no evidence to
support the effectiveness of this recommendation.

10,000 Steps Per Day

An alternative recommendation using pedometers encourages adults to take at
least 10,000 steps per day. Dr. Yoshiro Hatano of Japan, believes that taking 10,000
steps per day is the amount of physical activity needed for cardiovascular disease
prevention (37). Hatano has found that increased ambulatory activity is associated with
lower levels of blood pressure and subcutaneous fat (36). Hatano also estimated that a 60
kg Japanese male would expend at least 333 kcal/day in walking 10,000 steps/day (37).
Previous research by Paffenbarger et al. (85) indicates that this amount of energy
expenditure in physical activity (>2000 kcals/wk) appears to protect against heart attacks.
In addition, longitudinal studies have demonstrated that walking 10,000 steps/day results
in improvements in cardiovascular disease risk factors in sedentary, at-risk populations
(77, 121). This particular physical activity recommendation has been rather highly
publicized in popular periodicals (38, 96). To show the relative equivalence between the
ACSM/CDC recommendation and the 10,000 step/day recommendation, Wilde, et al.
(131) showed that by adding a 30-minute walk to their daily routine, subjects increased
their mean step counts from 7,220 to 10,030 steps per day. This study indicates that for
sedentary women, walking daily for 30 minutes will generally allow them to meet both
physical activity recommendations, suggesting that the two are roughly equivalent.
However, Wilde et al.i(131) also noted that although the mean step count of the
participants in this study was over 10,000 steps per day when they added a 30-minute ·
23

walk to their routine, only 37.5% took at least 10,000 steps on the first day they walked
an extra 30 minutes and just 50% took I 0,000 steps or more on the second day that
included a 30-minute walk. Therefore, although the recommendation to walk an
additional 30 minutes per day in addition to normal daily walking increased the mean
steps taken day from 7,220 to just over 10,000, the 30-minute walk was not enough to get
the majority of the participants over the 10,000 steps per day mark.

Physical Inactivity

Despite the abundance of literature supporting the benefits of leading a physically
active lifestyle, most Americans are not getting a sufficient amount of activity.
According to data collected from the CDC's Behavioral Risk Factor Surveillance System
(BRFSS), 55% of Americans were not active enough in 2001 to meet the current physical
activity recommendation of accumulating at least 30 minutes of any physical activity on
five or more days per week or more than 20 minutes of vigorous physical activity on
three or more days per week (16). Thus, although a variety of exercise recommendations
exist, a clear goal should be to provide a recommendation that will decrease the
prevalence of inactivity among American adults. Some factors that may potentially
impact physical activity participation include exercise intensity, exercise frequency,
group- vs. home-based exercise and an individual's willingness to adopt a physical
activity program.
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Exercise Intensity and Frequency

Exercise intensity may have a substantial effect on adherence rates to exercise
prescriptions. Some studies (2 1, 88, 100) have provided evidence that moderate-intensity
activity programs have greater adoption and adherence rates compared with those of
vigorous intensities. One of the suggested reasons for the decreased adherence to
vigorous-intensity activities is an increase in injury rates (20 , 92).
In 1986, Sallis et al. (100) found that exercise adoption rates were higher for
moderate- versus vigorous-intensity activities and that I -year dropout rates were greater
for vigorous-intensity activities. Likewise, a meta-analysis of 127 interventional studies
showed a greater increase in physical activity of low-intensity compared with that of
moderate- or high-intensity activities (2 1 ). Also, a review by Pollock showed that
exercise prescriptions of moderate-intensity were associated with greater adherence than
those of vigorous-intensity (92). In 2002, Perri et al. (88) compared the adherence to
walking based exercise prescriptions in a randomized, factorial design, with two levels of
intensity (moderate: 45-55% HRres vs. vigorous: 65-75% HRres) crossed with two levels
of frequency (moderate: 3-4 days per week vs. high: 5-7 days per week) for 30 minutes
per session over 6 months in a home based setting. The results showed better relative
adherence and a lower number of exercise-related injuries in the moderate-intensity than
in the high-intensity conditions and equivalent adherence for the moderate and high
frequency prescriptions. Likewise, participants in the higher intensity groups walked
significantly fewer total minutes than did participants in the moderate-intensity groups.
Thus, prescribing a higher frequency of exercise increased accumulation of exercise
without a decline in adherence, whereas prescribing a higher intensity decreased
25

adherence and resulted in the completion of less exercise. However, it should be noted
that although the vigorous intensity recommendation resulted in lower adherence, when
exercise volume, which takes into consideration absolute intens'ity, duration and
frequency of the activity (46), is expressed as kcalwk· 1 or MET-minwk· 1 , the higher
intensity group may not necessarily have done "less exercise" since the increased
intensity may offset the decrease in adherence.

Group versus Home-Based Exercise

Several studies have examined the effects of group- vs. home-based exercise in
regard to a variety of factors including exercise participation, adherence, fitness, and
weight loss. Perri et al. (89) showed that when subjects were given an exercise
prescription similar in type, intensity, duration and frequency, those randomly assigned to
home-based exercise experienced significantly greater improvements in exercise
participation, treatment adherence, and weight loss during the second 6 months of a 12month intervention than those assigned to group-based exercise. Moreover, although
both groups significantly improved their fitness levels in response to the 30 minutes per
day, 5 days per week exercise prescription, attrition was significantly lower in the home
based program compared with the group program.
King et al. (58) also compared the effectiveness of group- vs. home-based
exercise among healthy older adults. In this study, subjects were randomly assigned to
higher-_intensity, group-based exercise training; higher-intensity, home-based training;
lower-intensity, home-based training; or a control group. Regarding adherence, subjects
in both home-based programs reported significantly greater adherence than those in the
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group-based program. In fact, those assigned to home-based exercise had greater
adherence rates at each measurement period throughout the 12-month intervention. Thus,
it appears that the flexibility and convenience of a home-based exercise program appears
to affect adherence rates over the course of a long-term intervention.

Stages of Change

There is a trend in physical activity research to utilize psychological theories to
provide a framework for understanding, predicting, and changing behavior (72). An
individual's readiness to become physically active, which can be assessed using the
stages of change model, is clearly an important determinant of successful participation in
physical activity (72). The stages of change model developed by Prochaska and
DiClemente (94) is one of two different trans-theoretical models that have assisted
researchers who are interested in understanding and predicting changes in health-related
behaviors such as smoking, weight control, and physical activity (73). In developing the
stages of change model, Prochaska and DiClemente (94) suggested that individuals
engaging in a new behavior, such as physical activity move in an orderly progression
through the stages. Marcus et al. (73) describes these stages as they relate to physical
activity. The Precontemplation stage describes an individual who is not engaged in the
behavior of interest (i.e., exercise) and has no intention of becoming involved in that
behavior in the future. The Contemplation stage describes an individual who is not
engaged in the behavior of interest but is thinking about becoming involved in the
behavior in the near future. The Action stage describes an individual who has initiated
some behavior change (i.e., participation in occasional exercise). The Maintenance stage
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describes an individual who is regularly engaging in the behavior of interest (i.e.,
participates in the recommended amount of exercise). Exercise researchers have
recommended that this model be applied to exercise behavior, as the exercise field shifts
from predictive to process models to better understand behavior change as it relates to
physical activity (73).

Physical Activity and Cardiovascular Disease

Among the goals of virtually any exercise recommendation should be to
maximize adherence while improving cardiovascular disease risk factors. · It is well
known that cardiovascular disease is the leading cause of death in the United States
among both men and women. In addition, it is also well established that physical activity
is an important factor involved in the prevention and treatment of cardiovascular disease.
Hypertension, hypercholesterolemia, diabetes, and obesity are among the most
recognized risk factors for cardiovascular disease and physical activity is known to
positively affect each of them. Several cross-sectional and longitudinal studies have
documented the impact that leading a physically active lifestyle can have on altering each
of these risk factors in addition to decreasing cardiovascular disease mortality.

Hypertension

Hypertension or high blood pressure is among the leading causes of
cardiovascular disease, stroke, CVD mortality, heart failure, peripheral arterial disease,
and renal insufficiency (90). Commonly defined as a systolic blood pressure (SBP) �140
mm Hg and/or a diastolic blood pressure (DBP) �90 mm Hg or reported use of
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antihypertensive medications, hypertension is estimated affect 29% of American adults
(35). The prevalence of hypertension increases with age due to a loss of arterial
compliance and is higher among men than women at younger ages, but the reverse
appears to be true of older individuals (90). Despite the increased ability to detect and
treat hypertension, the prevalence of this condition remains very high (51). In addition,
hypertension appears to cluster with hypercholesterolemia, insulin resistance, glucose
intolerance and obesity, occurring in isolation less than 20% of the time (51). The
aforementioned risk factors further increase the severity of this condition with respect to
the development of cardiovascular disease.
Physical inactivity is generally associated with an increased risk for the
development of hypertension (85, 97). Reaven et al. (97) documented a dose response
inverse relationship between systolic and diastolic blood pressure and increasing levels of
physical activity. According to the American College of Sports Medicine Position Stand
entitled "Exercise and Hypertension", there is ample evidence to support the use of
physical activity as a means to prevent, treat, and manage hypertension (90). This
Position Stand recommends at least 30 minutes of continuous or intermittent moderate
intensity endurance physical activity (40-<60% of VO2Reserve) supplemented with
resistance training on most, preferably all days of the week (90) for those with
hypertension. There are several longitudinal, cross-sectional and interventional studies to
support the beneficial effects of physical activity on blood pressure.
Blair et al. (12) conducted a study in which normotensive men and women (SBP
::S140 mm Hg and DBP ::S90 mm Hg) ranging in age from 20-65 years, were followed for
up to 12 years for the development of hypertension. It was found that those with low
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levels of physical fitness, assessed by a maximal treadmill test, had a relative risk of 1.52
for the development of hypertension compared with those who were highly fit. In this
study, physical fitness was significantly associated with hypertension after adjusting for
potential confounding factors such as age, BMI, sex, and baseline blood pressure.
Similarly, Sawada et al. (103) showed that among Japanese males, the relative risk of
developing hypertension was 1.9 times higher in the least fit compared with the most fit
group even after adjusting for age, initial blood pressure, body fat, and other potential
confounding variables. Although the mechanism responsible for the reduction in blood
pressure associated with aerobic exercise is somewhat controversial, it may involve a
reduction in sympathetic nervous system activity, thereby lowering resting heart rate,
cardiac output and systolic blood pressure (4, 11).
Moreau et al. (77) conducted a study in which 24 postmenopausal women with
borderline to stage 1 hypertension (SBP 130-159 mm Hg and/or DBP 85-99 mm Hg)
were randomized into either an exercise group or a control group for 24 weeks. Those in
the exercise group were given an electronic pedometer and a target number of daily steps
that would lead to a 3-km increase in daily walking which is consistent with the
previously mentioned ACSM/CDC physical activity recommendation. After 12 weeks, .
SBP decreased significantly from 142 to 136 mm Hg and was further reduced by
5 mm Hg after 24 weeks in the exercise group who significantly increased daily walking
by 4,300 steps while SBP and DBP remained unchanged in the control group who did not
significantly change their walking volume. Diastolic blood pressure did not change
significantly in either group over the course of the study. The authors did note that the
reduction in blood pressure demonstrated in this study was unrelated to changes in body
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mass, percent body fat, fasting plasma insulin, or dietary intake. Seals et al. ( I 07) also
examined the effect of regular aerobic exercise for 12 weeks on blood pressure in high
normal to stage 1 hypertensive, postmenopausal women. The aerobic exercise training
consisted of walking at 50% of heart rate reserve (HRR) for 30 min·d- 1 , 3-4 days per
week and progressed after about 2 ½ weeks to 40-45 min·d- 1 at 60-7Q% of HRR for 4-5
days per week. After 12 weeks of exercise, SBP and DBP at rest decreased significantly
by 10/7 and 12/5 mm Hg respectively in the sitting and standing positions. It was also
noted that some decrease in blood pressure was observed in every subject and blood
pressure changes occurred in the absence of changes in maximal aerobic capacity, body
weight, or dietary intake.
Iwane et al. (48) examined the effects of walking 10,000 steps/day or more on
blood pressure in 30 mild essential hypertensive adult males. After 12 weeks,
participants walked an average of 13,510 steps per day which lowered systolic blood
pressure by 10 mm Hg suggesting that recommending 10,000 steps per day or more,
without guidance on exercise intensity or duration was effective in lowering blood
pressure in patients with mild essential hypertension. Similarly, Higashi et al. (40)
assessed the impact of daily walking on blood pressure in Japanese men and women with
essential hypertension. In response to 30 minutes per day of brisk walking, 5-7 times per
week, participants lowered systolic blood pressure from 155 to 147 mm Hg and diastolic
blood pressure from 96 to 92 mm Hg. Both these changes were significant decreases and
were also significantly different from the inactive control group whose blood pressure
remained essentially unchanged.
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Several meta-analyses (53, 54, 106) have been conducted examining the impact of
exercise training on blood pressure. Seals and Hagberg (106) conducted a meta-analysis
examining the effect of exercise training on hypertension and found most studies report
modest reductions in blood pressure (<10 mm Hg) at rest and during submaximal
exercise after training. Of the eleven studies reporting resting SBP and DBP values,
seven showed a significant reduction in SBP and eight found a significant reduction in
DBP. Among the eleven studies, the mean decrease in SBP was 9 mm Hg or 6% while
DBP decreased by 7 mm Hg or 7% on average. However, it was noted that studies
included in the analysis incorporated numerous methodological shortcomings and
inadequate study design suggesting that interpretation of the findings should be done with
caution. Kelley et al. (54) conducted a meta-analysis focus_ing specifically on walking
and its effects on resting blood pressure and showed that systolic and diastolic blood
pressures decreased significantly in response to walking interventions, independent of
changes in body mass. Sixteen studies were included in this meta-analysis and training
programs ranged in length from 4 to 52 weeks, frequency from 2 to 5 times per week,
intensity from 45 to 86% of VOimax, and duration from 28 to 60 minutes. Interestingly,
both systolic and diastolic blood pressure decreased about 2% in response to the
intervention. However, some of the potential effects of walking on blood pressure may
have been masked by the fact that several of the studies included in the meta-analysis
examined the blood pressure response of normotensive individuals in response to
exercise training. It is generally accepted that blood pressure changes following physical
activity interventions are greatest in hypertensives and may be minimal in normotensive
individuals (24, 52, 53, 79, 93).
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Despite the fact that variations exist in regard to the degree that blood pressure
changes in response to exercise training, it has been noted that even relatively small
decreases in blood pressure can result in significant health improvements. Stamler et al.
(114) estimated that a decrease of as little as 2 mm Hg in the average population SBP can
reduce mortality from coronary heart disease, stroke, and all causes by 4, 6, and 3%
respectively. Although differences exist in regard to the magnitude of blood pressure
change in response to regular aerobic exercise, it is thought that the effects of exercise on
blood pressure may be due differences in baseline blood pressures, demographic
characteristics, characteristics of the training program, inadequate controls, and blood
pressure assessment limitations (90). In regard to a gender comparison, meta-analytic
studies limited to randomized controlled trials found no significant differences between
resting blood pressure responses of normotensive and hypertensive men and women to
endurance training (52, 53).

Hyperlipidemia
Elevated lipid and lipoprotein levels are known to be among the most significant
risk factors for the development of cardiovascular disease. In addition, most efforts to
improve lipid and lipoprotein profiles begin _with a multifaceted approach that includes
increased levels of physical activity (28). Among the postulated benefits of physical
activity in preventing heart disease is a favorable effect on blood lipids, particularly an
increase in high-density lipoprotein cholesterol (HDL-C) (25, 26, 80, 82, 95, 105, 113).
A review by Leon and Sanchez (67) presented evidence showing the relationship
between physical activity and blood cholesterol levels from cross-sectional, longitudinal
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epidemiologic observational, and experimental exercise training studies. Cross-sectional
observational studies including both genders and all ages performing various aerobic
activities have consistently shown what appears to be a positive dose-response
association between the volume and intensity of aerobic activities and plasma HDL-C
and an inverse relationship with triglyceride (TG) levels (67). Among endurance
exercise training studies, the most commonly observed lipid change was an increase in
HDL-C. It was also noted that aerobic exercise training helped to negate or attenuate the
dietary-induced reduction in HDL-C, particularly in cases where substantial weight loss
has occurred. Although significant reductions in total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C), and TG occurred less frequently with exercise training
than an increase in HDL-C, it was noted that men typically experienced greater
reductions in TG than women in response to endurance exercise.
To assess the impact of exercise intensity on lipid/lipoprotein changes, Duncan et
al. (24) analyzed the effect of walking speed on cholesterol levels in 59 sedentary
postmenopausal women. Participants were randomized into one of four treatment
groups: aerobic walkers (8 kmh- 1 ), brisk walkers (6.4 kmH 1 ), strollers (4.8 k.m·h- 1 ), or
sedentary controls. After 24 weeks of training, HDL-C increased significantly among the
aerobic walkers and the strollers (6% increase in both groups), but not in the brisk
walkers (4% increase) or controls (1% increase). It was also noted that the TC:HDL ratio
decreased significantly within the strollers (7% decrease) but not in any other group.
Thus, this data suggests that vigorous exercise is not necessary for women to obtain
significant improvements in blood lipid profile. Crouse et al. (18) also conducted a study
examining the effect of exercise intensity on blood lipids. This study consisted of 26
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hypercholesterolemic men who trained at either a high (80% V02max) or moderate (50%
V02max) intensity, 3 days per week for durations calculated to result in 350 kcal of energy
expenditure per session. After 24 weeks, training intensity did not significantly affect
blood lipid profile when caloric expenditure was held constant. Suter et al. (1 18)
compared the changes in lipid/lipoprotein levels in sedentary men in response to jogging
or walking. Participants were randomized to one of two groups: jogging at 75% V02max,
4 times per week for 30 minutes per session or walking at 50% V02max, 6 times per week
for 30 minutes per session. After 6 months of exercise training, there were no significant
differences in lipid/lipoprotein levels between the two groups. Although it is difficult to
draw conclusions about the effect of exercise intensity on lipid/lipoproteins when other
components of the exercise prescription vary, from the abovementioned studies, exercise
intensity does not seem to affect lipid profile changes in men or women in response to
aerobic exercise training.
One question concerning the increase in HDL-C that may occur in response to
exercise training is whether the increase is dependent upon changes in body weight.
Higashi et al. (40) assessed the impact of daily aerobic exercise on lipoprotein levels in
men and women. The aerobic exercise consisted of 30 minutes of brisk walking, 5-7
times per week for 12 weeks. In this study, the exercise group noted significant
improvements in both HDL-C and LDL-C, despite no change in body weight. However,
there were no significant changes in TC or TG in response to the exercise intervention.
No significant changes occurred in any of the lipoprotein values in the control group.
Schwartz (105) determined the effect of dietary weight loss and aerobic training on HDL
C in obese men. In this study, 26 participants were randomized to either a diet or aerobic
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exercise group. The exercise consisted of a walk/jog program 3-5 days per week for 40
minutes per day at 70-85% HRR. After 3 months, those in the diet group lost
significantly more weight than those in the exercise group. In addition, TC, TG, and
HDL-C improved significantly within the diet group while only the HDL-C improved
significantly within the exercise group. However, in regard to the HDL-C subfractions,
the more anti-atherogenic HDL2 subfraction increased significantly in the exercise group
but not in the diet group. Thus, while diet and exercise can both impact HDL-C
independent of body weight change, exercise appears to be more effective at increasing
the more anti-atherogenic subfraction of HDL-C.
Sopko et al. (113) designed a study to analyze the independent effects of exercise
training and weight loss on blood lipids. Sedentary, obese men were stratified into one of
four treatment groups: 1) inactive and constant weight (controls), 2) exercise training and
constant weight, 3) inactive and weight loss, and 4) exercise training and weight loss.
The exercise training consisted primarily of walking 5 days per week at a 5-10% grade
with a total energy expenditure goal of 3500 kcal/week. After 12 weeks, TC decreased in
the exercise and weight loss group alone, LDL-C decreased only in the exercise and
weight loss group while increasing in all other groups, and HDL-C increased
significantly in all groups with the exception of the inactive and constant weight control
group. Thus, both exercise training alone and dietary induced weight loss in obese men
independently increased HDL-C similarly and the increase occurred independent of
changes in body weight.
Several studies that have examined the impact of walking alone on lipid and
lipoprotein levels have reported conflicting results (24, 44, 62, 76, 81, 102, 117, 132).
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Hinkelman and Nieman (44) examined the effects of walking five days per week for 45
minutes per day at 62% V02max for 15 weeks in overweight women. Although the
pattern of change in TG, TC, and LDL-C was not statistically different between the
exercise and control groups, the interaction for HDL-C was significant with HDL-C
actually increasing in the control group and decreasing slightly in the exercise group.
The authors suggested that the surprising increase in HDL-C noted in the control group
may have resulted from an increase in body weight.
Santiago et al. ( 102) assessed the impact of 3 miles of brisk treadmill walking up
a slight incline (5-7%) four times a week on blood lipid levels of sedentary women with a
high baseline HDL-C. After 40 weeks, no significant change was noted in blood lipid
variables despite a 22% increase in aerobic power. The authors concluded that the
unchanged HDL-C following the walking intervention may be attributed to either a lack
of change in body weight/percent body fat or to the favorable baseline blood lipoprotein
values of the women in this study.
Miyatake et al. (76) showed that daily walking can result in significant
improvements in lipoprotein levels in obese Japanese males. Although subjects were
instructed to walk 1000 steps more than their baseline steps per day value, the average
increase in daily walking was over 1,800 steps per day more than their baseline value,
which is roughly equivalent to an additional 1 mile of walking per day. After 12 months,
in addition to a significant reduction in body weight, TC remained unchanged, TGa.
decreased significantly and HDL-C increased significantly. Interestingly, both the
average TG and HDL-C at baseline were within normal limits suggesting that lipoprotein
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levels do not have to be abnormal initially to improve significantly in response to a
regular exercise program.
Woolf-May et al . (1 32) examined the efficacy of accumulated short vs. long bouts
of brisk walking on blood lipid levels in men and women. Participants were allocated to
one of four groups: long walkers (20-40 minutes/bout), intermediate walkers ( 1 0- 1 5
minutes/bout), short walkers (5- 1 0 minutes/bouts), and a control group. All three
walking groups were instructed to walk at an intensity equivalent to 70-75% V02max and
all three groups performed the same total amount of walking for the duration of the study.
After 1 8 weeks, all three walking groups showed similar improvements in fitness.
However, only the long and intermediate walkers statistically decreased their LDL-C
compared to the control group. No other significant changes in lipid/lipoprotein levels
were noted.
Nieman et al. (8 1 ) measured the impact of diet, exercise, and diet plus exercise on
lipid and lipoprotein risk factors in moderately obese women. The exercise consisted of
brisk walking for 45 minutes per day, 5 days per week at about 78% of maximal heart
rate. Relative to the control group, TC and TG decreased significantly in both the diet
and diet plus exercise groups, while LDL decreased significantly in the diet plus exercise
group alone following the 1 2-week intervention. Although HDL changes were
insignificant, HDL levels increased in the exercise group, decreased in the diet group and
remained unchanged in the diet plus exercise group. The authors of this study noted that
significant cholesterol improvements were most strongly related to weight loss.
Kraus et al. (62) examined the impact of exercise intensity and frequency on
changes in lipid/lipoprotein levels in sedentary overweight men and women. In this
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study, participants were randomized into a high-amount, high intensity group; low
amount, high-intensity group; low-amount, moderate intensity group; or a control group.
Interestingly, subjects were encouraged to maintain their baseline body weight. After
eight months, exercise training had no effect on the TC or LDL-C concentrations.
However, HDL-C increased significantly in the high-amount, high-intensity group while
increasing slightly in the low-amount, high intensity and low-amount, moderate intensity
groups. Thus, it was concluded from this study that improvements in lipoproteins were
related to the amount of activity and not to exercise intensity or the improvement in
fitness.
Sugiura et al. (117) also showed that daily walking can significantly improve
lipoprotein levels in sedentary, middle-aged women. The women in the exercise group
were asked to participate in a 90-minute physical education class consisting of walking,
jogging, or rhythm dance at 40-60% of VO2max once a week for 24 months in addition to
increasing their steps per day by 2,000 to 3,000 more than their baseline average daily
step count. Participants in the exercise group increased their daily steps from 6,800 to
over 8,500 steps while the control group increased their daily step count from 5,700 to
6,800 steps. In response to the intervention, TC, HDL-C, and the TC:HDL ratio
improved significantly while all lipid/lipoprotein values remained unchanged in the
control group. In addition, LDL-C also decreased nearly 20 mg/dL in the exercise group
although this change was not significant. A multiple regression analysis showed that TC,
HDL-C, and TC:HDL were significantly associated with daily steps, but were not
associated with the modest change in BMI. Thus, the improvements in lipid profile in
this study were attributed to the walking intervention and not the slight reduction in BMI.
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Kelley et al. (55) conducted a meta-analysis involving 25 randomized controlled
studies that assessed the relationship between walking and lipid/lipoprotein levels. The
studies assessed in this meta-analysis ranged in length from 1 0-104 weeks, frequency
from 3-15 times per week, intensity from 50-86% V02max, duration from 1 0-75 minutes
per session and compliance (defined as the percentage of walking sessions attended) from
50-100%. While all the changes in lipoproteins were in the direction favoring
improvement, statistically significant changes were limited to LDL-C and TC:HDL. The
average change for each lipid or lipoprotein level was as follows: TC (-3.4 mg/dL), HDL
C (1.2 mg/dL), LDL-C (-5-5 mg/dL) and TG (.2 mg/dL). It was concluded that the lack
of statistically significant improvements in TC, HDL-C, and TG may have to do with an
actual lack of effect of walking on these factors and/or the generally acceptable mean
baseline values of the subjects for these variables.
In regard to a gender comparison, it has been suggested that women may be more
resistant to physical activity induced changes in HDL-C and TG (44, 67). The most
likely explanation for this is that women have higher initial HDL-C concentrations than
men, thereby limiting the possibility of change (69). As with changes in blood pressure
in response to an exercise regimen, differences in the extent of blood lipid changes in
response to regular aerobic exercise and the differences in the magnitude of change
between genders may be due to differences in baseline blood lipid/lipoprotein values and
characteristics of the training program.
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Obesity Epidemic
In recent years, obesity has developed into a global epidemic. In 1998, the
American Heart Association issued a Call to Action that reclassified obesity as a major,
modifiable risk factor for coronary heart disease (27). In fact, the obesity epidemic may
be progressing much faster than our understanding of the etiology and our ability to
prevent and treat the disease (41). Recent evidence from the National Health and
Nutrition Examination Survey (NHANES) indicates that the prevalence of overweight
and obesity among adults in the United States is 64.5 and 30.5%, respectively (30).
Compared with data from NHANES III (1988-1994), current NHANES data (1999-2000)
showed that increases in the prevalence of overweight and obesity have been observed
among males and females and across all ages and racial/ethnic groups (30). It has been
estimated that by the year 2008, nearly 39% of the population will be considered obese
(43). In regard to the risk associated with obesity, the Rand Institute recently reported
that obese individuals have more overall health problems than smokers or drinkers (116).

Overweight and Obesity
In order to clarify the cause of weight change, it is necessary to understand the
various energy balance equations. When energy intake is equal to energy expenditure,
weight is maintained. In contrast when there is an imbalance between energy intake and
energy expenditure, weight changes will likely occur. In consideration of the dynamic
energy balance equation (122), if the rate of energy intake exceeds the rate of energy
expenditure, a positive caloric balance results and consequently, weight gain occurs. In
contrast, if the rate of energy expenditure exceeds the rate of energy intake, a negative
41

caloric balance results and therefore, weight loss occurs. Thus, from this information, it
can be gathered that the two alternatives for promoting weight loss are to decrease the
rate of energy intake and/or increase the rate of energy expenditure.
A meta-analysis by Miller et al. (75) examined the effectiveness of diet, exercise
or diet plus exercise on weight loss and found diet and diet plus exercise to be more
effective than exercise alone over the short-term. However, after one-year, diet plus
exercise tended to be the superior program, although the weight lost maintained at one
year did not significantly differ between the three conditions. Thus, it was concluded that
while diet alone and diet plus exercise may be most beneficial over the short-term, an
exercise component should be considered as part of the long-term intervention and/or
follow-up. Similarly, Skender et al. (110) compared the effects of diet-only, exercise
only and diet-plus-exercise on weight loss in 127 overweight men and women. The
dietary intervention was adjusted to produce a weight loss of I kg/wk while the exercise
component consisted of a home-based walking program, 3-5 days per week for up to 45
minutes per session. In regard to intensity, subjects were instructed to walk at a level that
felt "vigorous" but never "strenuous." Each of the three treatment conditions, which
lasted I year, were accompanied by a total of 18 group instructional sessions that were
conducted weekly for the first 12 weeks, followed by 3 biweekly sessions, followed by 3
monthly sessions. After I year, there were no significant differences (p=.09) among the
three groups. The diet-only group lost 6.8 kg, the exercise-only group lost 2.9 kg, and the
diet plus-exercise-group lost 8.9 kg. One year after completing the treatment, the
subjects were invited back for a follow-up examination. Interestingly, in the year
following the intervention, only 6.7% of the diet-only group and 14.3% of the diet-plus-
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exercise group reported adhering "often" to dietary recommendations. In contrast, 44%
of the exercise-only group reported exercising often during the year after treatment and
74.3% of the exercise-only group considered exercise to be enjoyable. In regard to
weight change after 2 years (1 year of intervention and 1 year of follow-up), the diet-only
group was .9 kg above their baseline weight while the exercise-only and the diet-plus
exercise groups were 2.7 and 2.2 kg below their baseline weights, respectively.
Despite the fact that diet often produces more substantial weight loss than
exercise over the short term, Ross et al. (99) demonstrated that diet-induced and exercise
induced weight loss can be equivalent as long as the energy deficit is equal. In this study,
obese men were randomly assigned to one of four groups: diet-induced weight loss,
exercise-induced weight loss, exercise without weight loss or an inactive control group.
Those in the diet-induced weight loss group were asked to reduce their isocaloric diet by
700 kcal/day to achieve a weekly weight loss of 0.6 kg. To lose the same amount of
weight, those in the exercise-induced weight loss group were asked to maintain their
isocaloric diet while performing exercise that expended 700 kcal/day. Participants in the
exercise without weight loss did the same amount of exercise each day as the exercise
induced weight loss group but were told to consume enough calories to compensate for
the energy expended during exercise (700 kcal/day). After 3 months, body weight
decreased by 7 .5 kg in both weight loss groups while remaining unchanged in the
exercise without weight loss and control groups. Thus, from this study it can be
concluded that as long as the caloric deficit is equal, exercise and diet can result in an
equally significant amount of weight loss.
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The observation that dieting often produces greater weight loss than exercise over
the short-term, and that exercise in combination with dieting often adds little to weight
loss by dieting alone is not surprising (74). It is unrealistic to expect a sedentary person
initiating an exercise program to achieve the same magnitude of energy deficit through
exercise that could be achieved through an energy restricting diet (74). However, as a
person trains, his/her ability to exercise for longer durations increases resulting in an
increase in energy expenditure. An additional benefit of training is the ensuing increase
in fat oxidation that may occur if training is of sufficient intensity and duration (74).
The origin of obesity can be traced to a variety of causes including metabolic,
genetic, behavioral, environmental, cultural and socioeconomic (1 28). Of these potential
causes, behavioral and environmental factors appear to be the most impressionable. The
current environment in the United States encourages consumption of energy and
discourages energy expenditure (6, 42, 43). Thus, the solution to the obesity problem
appears to lie in the identification of feasible ways or behaviors to cope with and to
change the current environment (43).

Walking

Walking is the most common type of physical activity in the United States (1 27).
It is the most natural form of activity and is the only sustained dynamic aerobic exercise
common to everyone with the exception of the seriously disabled or very frail (78).
Walking has the benefit of convenience, it may be accommodated in occupational and
domestic routines and it is self-regulated in intensity, duration and frequency and, having
a low ground impact; it is inherently safe (3 7, 78).
44

A recent study reported that approximately 34% of adults ages 18 and older
participated in regular walking, defined as walking at least five times per week for at least
30 minutes per session while an additional 46% reported walking occasionally, defined as
walking for at least I O minutes per time but did not meet the criteria for a regular walker
(29). Walking is an activity that can be done independently as most adults prefer to walk
on their own as opposed to in a supervised group setting (57). From a caloric expenditure
standpoint, walking at any pace expends energy; about 4 kJ/kg of body weight for every
kilometer walked (78). Thus, the cumulative effect of walking (like many other types of
physical activity) has the potential to impact energy balance in a manner that may
promote weight loss or weight maintenance.
Walking is one of the few feasible exercise regimens in the treatment of
overweight individuals because cardiovascular functional capacities are likely to be poor,
and other exercise such as jogging and aerobics may be hazardous (78). Gwinup (34)
suggested that walking would have to be recommended as the most practical form of
exercise for obese subjects who wish to lose weight. The physiological. response during
walking is determined by the intensity of the exercise in relation to the individual's
cardiovascular functional capacity (78). When walking at 4.8 km/hr (3.0 mph) on level
ground, oxygen uptake is about 3.7 METs regardless of age, sex, or level of fitness. One
MET is the energy requirement for resting. Therefore, the physiological stress of
walking at this intensity is far less for an individual with a VO2max of I �.0 METs
compared with an individual with a VO2max of 7.0 METs.
Walking is familiar, convenient, safe, readily habit forming and it requires no
special skills or equipment (45, 78). The benefits of walking extend to improvements in
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physical, cognitive, and social function, all of which enhance the 'health-related quality
of life' (98). While walking is generally considered to be a moderate intensity activity
(93), physical activity on a high-intensity level is not always feasible for certain
populations including the elderly, overweight, untrained, and individuals with
cardiovascular disease (118). Thus, walking may be the ideal activity for such
populations. Walking is a rhythmic, dynamic, aerobic activity of large skeletal muscles
that confers the various benefits with minimal adverse effects.

Walking and Weight Status
Studies that have assessed the relationship between physical activity and body
weight have generally reported that overweight people perform less physical activity.
Chirico and Stunkard (1 7) showed that obese men and women walked significantly fewer
miles per day than non-obese men and women. Similarly, Tyron et al. (126) reported a
significant negative correlation between percentage overweight and physical activity. It
was noted that as percentage overweight increased, physical activity reported as miles
walked per hour decreased. Likewise, the prevalence of obesity has been shown to be
lower in more active individuals. Tudor-Locke et al. (125) noted that the prevalence of
obesity was only 10% among those taking more than 9,400 steps/day, compared to 40%
among those taking less than 5,300 steps/day. Similarly, Thompson et al. (123) assessed
the relationship between accumulated walking and body composition specifically in
middle-aged women and noted significant negative correlations between steps per day
and percent body fat (-.71), BMI (-.42), waist circumference (-.62), hip circumference
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(-.28), and waist:hip ratio (-.65). In addition, when participants were stratified into
activity tertiles, significant differences in body composition variables were noted among
the activity groups. Although these studies demonstrate an association between physical
activity and weight status/body composition, they are unable to establish a cause and
effect relationship. However, whether a decrease in physical activity is a cause or an
effect of obesity, inactivity contributes to a positive energy imbalance and thereby
exacerbates the problem (126).

Walking and Fitness
Several studies have examined the relationship between walking and fitness (14,
93, 102, 118). In 1994, Suter et al. (118) compared the effects of walking (50% V02max)
and jogging (75% V02max) programs that elicited similar values for weekly energy
expenditure in sedentary men. After 6 months of training, the walking and jogging
groups increased V02max significantly by 2.5 and 2.9 ml/kg/min, respectively while the
control group experienced a decrease in V02max by 1.2 ml/kg/min. The results of this
study showed that the amount of training in terms of energy expenditure, which was
about the same for both groups, rather than the intensity was the important criterion for
improvement in cardiovascular fitness.
Pollock et al. (93) assessed the effect of walking 4 times/week for approximately
40 minutes for each training session for a total of 20 weeks on middle-aged men.
Subjects in this study were encouraged to walk as far as possible in each 40-minute
session. Walking distance increased from 2.5 miles during week 1 to 3.25 miles for the
final 4 weeks of the study. As a result of training, V02max increased from 2.30 to 2.94
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L/min (28% increase), one-mile walk time decreased by over 1 ½ minutes ( 17%
decrease), and heart rate response decreased significantly at each of the three stages of a
standard treadmill walk and remained decreased up to 5 minutes into recovery, all factors
indicating improved cardiovascular fitness.
Lynch et al. (70) determined that visceral fat reduction following a weight loss
intervention which included a reduced calorie diet and a walking program, was
significantly related to improvements in V02max, The walking program in this
intervention consisted 30-40 minutes of exercise, 3 days per week at a target heart rate of
50-60% HRR. In comparing those that increased their aerobic fitness by an average of
10% with those that showed no increase, those that increased their V02max experienced
significant reductions in visceral adipose tissue area.
In 1989, Blair et al. showed that significantly lower death rates may be related to
moderate levels of physical fitness (14). In a prospective study involving over 3,000
women and 10,000 men, there were significant differences in mortality between
individuals in the least fit quintile and those in the next "moderately fit" quintile. The
encouragement in this study lies in the fact that these differences in fitness represent a
degree of improvement that should be achievable by brisk walking (13, 78). With an
emphasis on the personal and public health gain associated with the shift from the
inactive/unfit to the next higher level, walking is the ideal mode to serve the transition
(87).
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Physical Activity and Weight Management
In 1999, Serdula et al. (108) reported that the prevalence those attempting to lose
and maintain weight was 28.8% and 35. 1% among men and 43.6% and 34.4% among
women, respectively. Several studies have examined the impact of regular walking on
body composition variables. However, differences in exercise prescription, baseline
characteristics, and measurement methods make direct comparisons among studies
difficult. Nonetheless, it is possible to look at the effect of different components of the
exercise prescription on changes in body composition.

Continuous versus Intermittent Exercise
The current ACSM/CDC physical activity recommendation suggests that
accumulated physical activity (intermittent bouts of physical activity, as short as 8- 10
minutes each, totaling 3 0 minutes or more) can provide equivalent health and fitness
benefits as can continuous physical activity as long as the total amount of activity
performed, expressed either in terms of caloric expenditure or minutes of activity, is the
same (87). Several studies have examined the impact of continuous versus intermittent
exercise on body weight change and have reported conflicting results.
Donnelly et al. (23) investigated the effects of continuous vs. intermittent exercise
on body composition in moderately obese females. Those randomized to the continuous
group exercised for 30 minutes at 60-75% V02max, 3 times per week under direct
supervision while those in the intermittent group were instructed to walk briskly, yet
comfortably at approximately 50-65% HRR, 2 times per day, 15 minutes per session, 5
days per week at their home or worksite. Although the volume of exercise differed
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between the two groups with the continuous group expending 223 5 kJ per week
compared to 3235 kJ per week in the intermittent group, only those in the continuous
group noted significant reduction in body weight and percent body fat after 18 months.
However, the fact that only the continuous group exercised under direct supervision may
have influenced these results.
Jakicic et al. (50) also examined the effects of continuous vs. intermittent
exercise. In this study, the duration of exercise was set at 20 minutes per day for weeks
1 -4, 30 minutes per day for weeks 5-8, and 40 minutes per day for weeks 9-20.
Participants in the continuous group were told to walk the specified duration in one
continuous bout while those in the intermittent group were told to perform the specified
duration in multiple 1 0-minute bouts per day. Both groups were instructed to walk 5
days per week at 70% of HRR. After 20 weeks, both body weight and BMI decreased
significantly in both groups although the group by time interaction suggested that there
was a trend for the intermittent group to have a greater magnitude of weight loss
compared to the continuous group. This may be due to improved adherence as the
intermittent group reported exercising significantly more days and for a greater total
duration.
Schmidt et al. (104) compared the effects of continuous versus intermittent
exercise in overweight college aged females. Participants were assigned to one of four
groups: a nonexercising control group, 30 minutes of continuous exercise group, 30
minutes of accumulated exercise group (2, 15 minute bouts per day) and a second 30
minutes of accumulated exercise group (3, 10 minute bouts per day). The exercising
subjects participated in aerobic exercise training at 75% HRR, 3-5 days per week. In
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addition, subjects were also asked to follow a self-monitored calorie restricted �iet (80%
of resting energy expenditure) for the duration of the study. After 12 weeks, body
weight, BMI, the sum of 7 skinfold sites, and the sum of 4 circumference measurements
all decreased significantly in the three exercise groups while remaining unchanged in the
control group. Unlike the findings of Jakicic et al. (50), exercise participation did not
differ among the exercising groups with regard to the average number of days spent
exercising per week.
Murphy and Hardman (79) examined the effects of short and long bouts of
physical activity in sedentary, middle-aged women. Participants in the short bouts group
performed three 10-minute bouts of walking while those in the long bout group
performed one 30-minute bout of walking. Both groups were instructed to walk briskly
at 70-80% of their maximal heart rate, 5 days per week. In addition, subjects also agreed
not to make any changes in their diet. After 10 weeks, body mass and waist
circumference decreased significantly in the short bout group alone, while the sum of 4
skinfolds decreased significantly in both exercise groups in comparison with the inactive
control group. In this study, total time spent in brisk walking did not differ significantly
between the two walking groups.
Thus, although the data comparing continuous and intermittent exercise appear
conflicting, three of the four studies mentioned suggest that exercise accumulated in
bouts of at least 10 minutes each are at least as beneficial in reducing body weight as one
· continuous bout as long as the total amount of activity performed is equal. However, it
should be mentioned that although changes in body mass are noted in each study,
changes in fat mass, which are more desirable, are not consistently reported.
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Exercise Intensity and Weight Management
Several studies have examined the effect of varying exercise intensities on body
weight changes. Slenz et al. (111) compared eight months of varying amounts of
exercise on body weight and body composition. In this study, sedentary, overweight men
and women were randomized into one of four groups: a high amount/vigorous intensity
group, a low amount/vigorous intensity group, a low amount/moderate intensity group, or
an inactive control group. Despite being counseled to maintain baseline body weight, all
three exercise groups lost a significant amount of body weight and fat mass compared
with the inactive control group. In comparing those that did the same amount of exercise
but at different intensities (low amount/moderate intensity vs. low amount/vigorous
intensity), there was no significant difference in the decrease in body weight or fat mass.
In fact, the authors noted that there were no variables for which the low-amount/vigorous
intensity group was significantly better than the low-amount/moderate intensity group.
Based on the fact that none of the four groups made any significant changes in mean
caloric intake or in carbohydrate, fat, or protein intake, the changes noted are likely due
to the increase in physical activity among these previously sedentary individuals.
Suter et al. (118) compared the effects of walking vs. jogging on several body
composition variables. In this study, sedentary, nonsmoking men were randomized into
either a home-based unsupervised exercise program consisting of jogging at 75% V02max
for 4 days per week for 30 minutes per day, walking at 50% V02max for 6 days per week
for 30 minutes per day, or an inactive control group. After 6 months, there were no
significant changes between either the joggers or walkers in body fat determined by
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skinfold measurements or fat distribution as determined by waist:hip ratio. One likely
explanation for a lack of change in body composition variables is that all three groups
had a mean BMI of24.9 kg·m-2 suggesting that the groups were not overweight at the
onset of the study. Interestingly, although there was no change in body fat on average in
either exercising group, a significant association between the amount of training and a
decrease in the sum of skinfolds and waist:hip ratio was observed only in the walkers.
Similarly, Santiago et al. (101) compared the physiological responses of sedentary
women to a conditioning program of walking or jogging. Participants consisted of 40
slightly overweight, sedentary women randomized into either a walking group, jogging
group or an inactive control group. The exercise prescription was standardized with
respect to distance (4.8 km/session) and frequency (4 days/week). After 20 weeks, there
were no significant changes in body weight, percentage of body fat, or the sum of five
skinfolds for any of the three groups. As is the case in the Suter et al. study, there was no
mention of a dietary analysis and thus, it is possible that in both studies, the walking and
jogging groups had a compensatory increase in caloric intake that could have masked any
potential changes in body weight that may have resulted from the increase in physical
activity.
A study by Duncan et al. (24) assessed the impact of the intensity of walking
alone on body composition variables. Sedentary middle-aged women were randomized
into one of four treatment groups: aerobic walkers (8 km/hr), brisk walkers (6.4 km/hr),
strollers (4.8 km/hr) or sedentary controls. Each group was instructed to walk 4.8 km/day
(3 miles), 5 days per week. Caloric intake, dietary fat, carbohydrate, and protein intake
remained unchanged in all four groups over the course of the study. After 24 weeks, all
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groups gained weight with the exception of the brisk walkers. The brisk walkers were the
only group in which their change in body weight was significantly different from that of
the control group. In regard to percent body fat, only the change among the strollers was
significantly different from the controls. However, it is interesting to note that while
none of the exercising groups lost body weight in response to the intervention, all three
exercise groups decreased their body fat percentage on average while the control group
increased their percent body fat.
Likewise, Asikainen et al. (5) also looked at the effect of varying intensities of
walking on body weight and body composition. In this study, sedentary, non-obese,
postmenopausal women were randomized to one of five groups: walking at 55% V02max
with a caloric goal of 1500 calories per week, walking at 45% V02max with a caloric goal
of 1500 calories per week, walking at 55% V02max with a caloric goal of 1 000 calories
per week, walking at 45% V02max with a caloric goal of 1000 calories per week, or an
inactive control group. Each walking group was instructed to walk 5 days per week for
24 weeks. In addition, while no significant differences were noted between body weight
change in the walkers vs. the controls, there were significant differences between the
walkers and the controls in respect to change in body fat percentage. Although there was
no clear dose-response relation between exercise intensity, changes in body weight or fat
weight, percent fat did decrease in each of the walking groups while increasing slightly in
the control group, a finding similar to that of Duncan et al. (24). Thus, while walking did
not produce a significant amount of weight loss in all three groups, it did limit the
increase in percent fat that occurred in the control group.
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Although studies have made comparisons between the effects of walking at
various intensities, it is difficult to weigh the impact of intensity alone when other
variables of the exercise prescription such as frequency and duration vary. However,
from the aforementioned studies that focused on walking alone, it appears that walking
intensity does not significantly affect body weight or body composition changes. This is
in agreement with Ballor and Keesey who have suggested that if weight regulation is the
goal, it appears that walking pace is not as important as regularity and duration (6). In
addition, Jakicic and Gallagher (49) noted that exercise prescribed at a relatively high
intensity may increase the risk associated with exercise participation in sedentary,
overweight adults, particularly when other cardiovascular disease risk factors are present.

Walking and Weight Management
In addition to the abovementioned studies that have looked at exercise of varying
intensities in addition to continuous vs. intermittent exercise, other studies have examined
the effect of walking for various durations and frequencies on body weight and body
composition. However, the results from these studies are equivocal. Possible reasons for
the lack of agreement may be due to the differences in subject characteristics, training
protocols, and the durations of the interventions, which make it difficult to directly
compare results between individual studies.
In 1975, Gwinup (34) reported on the effect of exercise alone on the weight of
obese women. In this study, eleven obese women progressively increased their amount
of walking for one year or longer while on an ad libidum diet. Exercise time was divided
into one, two, or occasionally three periods daily and subjects were advised to walk as
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rapidly as could comfortably be tolerated. Weight loss over the I -year intervention
averaged 10 kg and ranged from 4.5 to 17.3 kg. In general, the amount of weight loss
paralleled the amount of exercise with the most active individuals losing the greatest
amount of weight. Interestingly, it was noted that weight loss did not begin until walking
exceeded 30 minutes daily, with the exception of two subjects who were somewhat active
when they began the study. Thus, it was concluded that exercise alone can produce
substantial and sustained weight loss in women who exercise for long durations on a
daily basis.
Moreau et al. (77) determined the impact of an increase in daily walking on body
weight and body composition in postmenopausal women with borderline to stage 1
hypertension. In being instructed to walk an additional 3 km per day, the women
increased their daily walking from 5,400 steps/day to 9,700 steps/day. As a result, the
women engaged in the walking intervention lost a statistically significant 1.3 kg of body
mass after 24 weeks, despite the fact that body fat percentage remained essentially
unchanged.
Miyatake et al. (7 6) assessed the effect of daily walking on body composition in
obese, Japanese men. In this study, participants were instructed to walk an additional
1,000 steps per day above their baseline level. After 1 year, participants increased their
daily walking significantly from 7,0 13 to 8,840 steps per day while reducing their caloric
intake by a statistically insignificant 95 calories per day, which resulted in a significant
reduction in body weight (-3.7 kg), body fat mass (-2.8 kg), waist circumference (-4.6
cm), hip circumference (- 1.6 cm), and body fat percentage (-2.5%).
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Pollock et al. (93) determined the effect of a 20-week walking program of
moderate- to high-intensity in sedentary middle-aged men. The training program
consisted of walking 4 days/week for approximately 40 minutes per day. After the 20week intervention, body weight (-1.3 kg), percent body fat (-1.1%), abdominal (-0.7 in)
and gluteal (-0.3 in) circumferences all decreased significantly. Percent body fat
increased significantly in the control group while all other body composition and girth
measurements remained unchanged.
Leon et al. (66) examined the effects of a vigorous walking program on body
composition of young, obese men. The walking program increased from one, 15-minute
walk at 1.5 mph walk up a 10% grade each session for 5 days per week to three, 30minute walks at 3.2 mph up a 10% grade each session for 5 days per week. After 16
weeks, significant decreases were shown in body weight (-5.7 kg), BMI (- 1 .8 kg·m-2), and
fat weight (-5.9 kg). In addition, significant decreases in 5 of the 7 skinfold
measurements also occurred in response to 16 weeks of vigorous walking.
A study by Parkkari et al. (86) assessed the impact of golfing 2-3 times per week
on health outcomes in previously sedentary overweight, middle-aged men. It was found
that low intensity walking equivalent to 15-20 km per week resulted in significant
improvements in aerobic performance, body weight (-1.4 kg), waist circumference (-2.2
cm), and abdominal skinfold thickness (-2.2 cm).
Yamanouchi et al. (133) compared the effects of diet and diet plus exercise on
insulin sensitivity and body weight in obese patients with non-insulin dependent diabetes
mellitus. The diet consisted of a daily caloric intake equivalent to 1,000 kilocalories (5458% carbohydrates, 17-20% protein, and 25-26% fat) below their usual self-reported
57

intake. The diet plus exercise group was instructed to walk at least 1 0,000 steps/day.
Over the course of the intervention the diet only group walked an average of 4,500 steps
per day while the diet plus exercise group walked 1 9,200 steps/day. As a result, the diet
plus exercise group lost significantly more body weight than the diet only group (7. 8 vs.
4.2 kg).
Hinkleman and Nieman (44) assessed the benefits of a walking program on body
composition of overweight, sedentary women. The training program consisted of
walking five days per week, for 45 minutes per day at an intensity equivalent to 62%
V02max· After 1 5 weeks, there were no significant changes in body weight, body fat
percentage, fat weight or lean weight in the walking group while body weight, fat weight,
and lean weight all increased significantly in the inactive control group. Thus, while the
walking intervention did not produce weight loss, it did help to prevent the weight gain
(1 .7 kg) that occurred in the control group.
Similarly, Snyder et al. ( 1 1 2) found that a long-term, moderate intensity
intermittent exercise program failed to improve body weight or body composition in
overweight females. The intervention consisted of moderate intensity exercise 5 days per
week for 30 minutes per day (3 , 1 0 minute bouts). After 32 weeks, body weight, percent
body fat, and waist:hip ratio remained unchanged. Surprisingly, energy intake and
nutrient composition estimated by 24-hour recall remained unchanged. Although body
weight and body composition remained unchanged in the group as a whole, 7 of the 1 3
participants experienced significant decreases in fat weight and waist:hip ratio while the
remaining 6 subj ects significantly increase fat weight over the course of the intervention.
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Thus, it was suggested that among overweight, middle-aged females, there may be
responders and non-responders to the same intervention.
Swartz et al. (121) examined the impact of a I 0,000 step/day recommendation on
glucose and insulin dynamics in overweight women. Subjects in this study increased
their daily walking from 4,972 to 9,213 steps/day. Despite improvements in 2-hour
plasma glucose levels and the area under the curve for glucose, body weight essentially
remained unchanged, which is likely due to the relatively short duration of the study (8
weeks).

Gender Comparison
Although several studies have assessed the impact of walking on body
composition in men and women, very few have compared the gender effect in response to
the same intervention. Although exercise has been shown to be an effective tool for
weight management, its effects may be influenced by gender. A meta-analysis of 40
studies by Bailor and Keesey provided evidence that males lost more body mass than
females in response to run/walk exercise interventions (6). It was suggested that males
participating in the studies were heavier and relatively more fat than the females resulting
in increased energy expenditure per session which may have contributed to the greater
body mass reduction observed in males.
Kirk et al. (59) showed that both males and females significantly improved
aerobic capacity in response to an exercise program of equal intensity and duration, but
only the males lost a significant amount of body weight after the 16-month intervention.
The exercise regimen progressed from 3 days per week for 30 minutes per session at 60%
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HRR for the first 4 months and was increased to 5 days per week for 45 minutes per
session at 75% HRR and was maintained for the duration of the study. It was noted that
energy intake was not restricted and remained unchanged throughout the duration of the
study. After 9 months, males significantly decreased body weight (-5.3 kg) and fat
weight (-5.0 kg) and maintained the weight loss throughout the remainder of the study.
However, females did not significantly decrease their body weight or fat weight over the
16-month intervention. Similarly, Snyder-Heelan et al. (1 12) found that only the males
lost a significant amount of body weight in response to an exercise program with a goal
energy expenditure of 420 kcal/session. In this study, moderately obese males and
females were randomized to an exercise group (5 days per week for 45 minutes per
session at 70-85% HRR) or an inactive control group. After 66 weeks, the males in the
exercise group lost a significant amount of body weight (-5.1 kg) while the females in the
exercise group increased body weight slightly (0.8 kg). Although this amount of exercise
was not effective for weight loss in females, it did serve to limit weight gain that occurred
in the female control group (4.e1 kg) over 66-week intervention.
In 2003, Donnelly et al. (22) compared the long-term effects of supervised,
moderate-intensity exercise on body weight and body composition in previously
sedentary, overweight and moderately obese men and women. The training protocol
consisted primarily of walking on a motor-driven treadmill 5 days per week and
progressed in intensity from 60% of the HRR at baseline to 75% HRR at 6 months and
duration from 20 minutes per session at baseline to 45 minutes per session at 6 months.
The targeted minimum energy equivalent for exercise was approximately 400 kcal per
session. After 16 months, the men averaged 668 kcal per exercise session and the women
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averaged 439 kcal. In addition, the men experienced significant decreases in body weight
(-5.2 kg), BMI (- 1.6 kg/m-2), and fat mass (-4.9 kg) compared with men in the control
group. Women who exercised maintained body weight, BMI, and fat mass while the
women in the control group experienced significant increases in these three variables
after 16 months. Although the women in this study did not lose weight, the exercise
regimen did attenuate weight gain in the women who exercised compared with women in
the control group. At 16 months, the women who exercised had significantly lower body
weight, BMI, and fat mass compared with the controls. Interestingly, no significant
differences were found either between or within groups across the 16-month intervention
in total energy intake or macronutrient intake for men and women at any point in the
study. It was concluded that 16 months of moderate-intensity exercise prevented weight
gain in women and produced weight loss in men. Thus, it was suggested that 225
minutes of moderate-intensity exercise per week may be a guideline for the amount of
exercise necessary to prevent weight gain in young women and produce weight loss in
young men.
From studies directly comparing the male and female response to exercise
training, it can be surmised that males are more likely to lose weight while females are
more likely to maintain their weight following an exercise intervention. Interestingly,
animal research supports these findings in that a gender specific response in regard to
body mass and exercise training has consistently been noted with females conserving and
males reducing body mass in response to exercise training ( 19, 83 ).
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Summary

Although the results regarding the effect that regular walking has on body
composition are not in complete agreement, there is substantial evidence suggesting that
that walking can positively influence body composition variables. As is the case with ·
changes in blood pressure and lipid/lipoprotein levels in response to a walking
intervention, differences in baseline subject characteristics and training protocol likely
contribute to some of the noted discrepancies. In addition, considering the impact that
energy intake can have on body composition changes, the fact that several studies failed
to account for this important factor makes it difficult to focus on physical activity alone
as the factor influencing body composition changes. Nevertheless, there are plenty of
reasons to believe that exercise can favorably alter body composition. Along with the
increase in energy expenditure that accompanies physical activity, time spent exercising
is also time spent away from food, which positively affects both sides of the energy
balance equation. In addition to being a tool for promoting weight loss, walking can also
be used as an activity to prevent weight regain following a physical activity intervention
(3 1 ). In fact, data from the National Weight Control Registry has shown that the
maintenance of exercise is one of the major factors associated with the maintenance of
weight loss (60).
It also well known that physical activity can affect variables other than body
composition, blood pressure and blood cholesterol. It is generally agreed that increased
physical activity can result in significant psychological benefits. Gwinup noted that
although many of the subjects indicated that they did not enjoy the exercise periods, most
were quite pleased about the results achieved and particularly about the general feeling of
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wellbeing they experienced. They commented that weight loss through exercise, unlike
that previously achieved through dieting, was not accompanied by feelings of weakness
and increased nervousness, but rather by feelings of increased strength and relaxation
(34).
Given the vast potential for physical activity to alter a wide range of health related
variables, it is essential to not only encourage the inactive to become more physically
active but also to encourage those who are physically active to maintain it. It is important
to note that regular exercise may elicit health benefits such as improved cardiorespiratory
fitness (82), blood lipid profile (40), blood pressure ( 107), and blood sugar control ( 121),
even in the absence of a weight reduction (130). As noted by Donnelly et al. (22) our
challenge now is to develop means of achieving sustained increases in exercise (or
physical activity) in young men and women.
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PART III

ACCURACY AND RELIABILITY OF TEN PEDOMETERS FOR
MEASURING STEPS OVER A 400-M WALK
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Abstract
Purpose: The purpose of this study was to determine the accuracy and reliability of the

following electronic pedometers for measuring steps: Freestyle Pacer Pro (FR), Kenz
Lifecorder (KZ), New Lifestyles NL-2000 (NL), Omron HJ-105 (OM), Oregon Scientific
PE316CA (OR), Sportline 330 (SL330) and 345 (SL345), Walk4Life LS 2525 (WL),
Yamax Skeletone EM-180 (SK), and the Yamax Digi-Walker SW-701 (DW).
Methods: Ten males (34.7 ± 12.6 yrs), (meana± SD), and ten females (43.1 ± 19.9 yrs)

ranging in BMI from 19.8 to 33.6 kg · m·2 walked 400-m around an outdoor track while
wearing two pedometers of the same model (one on the right and left sides of the body)
for each of ten models. Four pedometers of each model were assessed in this fashion.
The actual steps taken were tallied by a researcher. Results : The KZ, NL, and DW were
the most accurate in counting steps, displaying values that were within ± 3% of the actual .
steps taken, 95% of the time. The SL330 and OM were the least accurate, displaying
values that were withina± 37% of the actual steps, 95% of the time. The reliability within
a single model (Chronbach's alpha) was >0.80 for all pedometers with the exception of
the SL330. The intra-model reliability was exceptionally high (>0.99) in the KZ, OM,
NL, and the DW. Conclusion: Due to the variation that exists among models in regard
to the internal mechanism and sensitivity, not all pedometers count steps accurately.
Thus, it is important for researchers who use pedometers to assess physical activity to be
aware of their accuracy and reliability.
Key Words: steps, step counter, physical activity, motion sensor, walking
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Introduction

Prospective epidemiological studies support the belief that a physically active
lifestyle can lower the risk of developing various chronic diseases such as coronary artery
disease, Type 2 diabetes mellitus, hypertension, and obesity (1 ). With an emphasis on
promoting a physically active lifestyle, numerous studies have examined the practicality
and feasibility of using the pedometer as a tool for measuring physical activity levels
( 10,l l , 17,22,23,28,29). Pedometers are devices that are typically worn at the waist and
are capable of counting steps. Some models also calculate distance and estimate energy
expenditure. Pedometers are a means of objectively measuring ubiquitous, ambulatory
activity as well as many types of structured physical activities (24 ).
The three main areas in which pedometer models may differ are cost, mechanism,
and sensitivity of the device. There is considerable variation in the cost of a pedometer
which can range anywhere from $ 10 to $200. Given the wide range of costs of various
pedometers, a less expensive pedometer becomes an attractive option for those wanting
to do large-scale studies. Thus, it would be of interest to determine if some of the less
expensive pedometers are as accurate as some of the more costly versions. The internal
mechanism is also a distinguishing point among the various brands and models of
pedometers. There are three primary mechanisms by which pedometers function. The
first type uses a spring-suspended horizontal lever arm that moves up and down in
response to the hip's vertical accelerations. This movement opens and closes an
electrical circuit; the lever arm makes an electrical contact (metal-on-metal contact) and a
step is registered. The second type of mechanism is a magnetic reed proximity switch.
With this mechanism, a magnet connected to a spring-suspended horizontal lever arm
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within the pedometer moves up and down with each vertical acceleration of the hip. The
magnetic field triggers a proximity switch encased in a glass cylinder and a step is
counted. The third type uses an accelerometer-type mechanism consisting of a horizontal
beam and a piezo-electric crystal. Pedometers using this particular mechanism can
distinguish between differing intensities of exercise when estimating caloric expenditure.
Finally, pedometers may also differ in their sensitivity, which is a function of the vertical
acceleration "threshold" needed to trigger a step. Although this issue is related to the
mechanism, the sensitivity of the internal mechanisms of different pedometers can vary
as can the quality of the mechanism itself.
In general, pedometers are most accurate in counting steps, less accurate in
calculating distance, and even less accurate at estimating energy expenditure (2,4). Since
steps are the most direct expression of what the pedometer actually measures (25), most
researchers recommend reporting pedometer data as steps (4,25). A previous study
conducted by Bassett et al. (2) assessed the accuracy of five electronic pedometers in
measuring distance walked and steps taken on a sidewalk course and found that
pedometers varied significantly in the pedometer-calculated distance over 4.88 km. Due
to the potential for such inaccuracies between pedometer models, it is essential that
pedometers be tested for accuracy.
In addition to the variation that exists between models, it is possible for
discrepancies to exist within a particular pedometer model (intra-model reliability).
Given the potential for differences in manufacturing tolerances and design specifications,
it is conceivable for devices of the same model to differ significantly in steps counted.
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Thus, it is evident that the reliability of pedometers within a particular model should be
assessed.
· Considering the fact that a great number of pedometer models have been
introduced in recent years and that variability exists not only in the cost but also in the
mechanism and sensitivity among pedometers, it would be beneficial to determine the
accuracy of a variety of pedometers. In addition, the only multi-brand comparison was
carried out in 1996 (2), and none of the pedometers that were assessed at that time are
currently available. Therefore, the purpose of this study was to determine the accuracy
and reliability of ten electronic pedometers for counting steps.

Methods

Pedometers
Ten models of commercially available electronic pedometers were assessed in this
study: Freestyle Pacer Pro (FR), Kenz Lifecorder (KZ), New Lifestyles NL-2000 (NL),
Omron HJ-105 (OM), Oregon Scientific PE316CA (OR), Sportline 330 (SL330) and 345
(SL345), Walk4Life LS 2525 (WL), Yamax Skeletone EM-180 (SK), and the Yamax
Digi-Walker SW-701 (DW). Pedometer characteristics are presented in Table 1.

Subjects
Ten male and ten female adults (22-69 yrs of age) volunteered to participate in the
study. The procedures were reviewed and approved by the Institutional Review Board at
the University of Tennessee. Each subject completed a Physical Activity Readiness
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Table 1 . Pedometer characteristics
Model
Country of
Model

Mechanism

Features

China

M-M

S, D, C

Manufng.

Approx.
�Ost

$20

Freestyle

Pacer Pro

Kenz

Lifecorder

Japan

Accelerom.

S,eC*

$200

New Lifestyles

NL-2000

Japan

Accelerom.

S,eC*

$50

Omron

HJ- 1 05

China

Reed

S,eD, C

$27

Oregon Scientific

PE3e1 6CA

China

Reed

S, D, C

$20

Sportline

330

Taiwan

M-M

s

$13

Sportline

345

Taiwan

M-M

S, D, C

$30

Walk4Life

LS 2525

Taiwan

M-M

S, D, C

$29

Yamax

Skeletone

Japan

Reed

s

$15

Yamax

SW-70 1

Japan

M-M

S, D, C

$30

Mechanism: Metal-on-metal (M-M), Accelerometer (Accelerom.), Magnetic Reed
Proximity Switch (MRPS)
Features: Steps (S), Distance (D), Calories (C)
* Indicates pedometers that estimate both gross and net caloric expenditure
Approx. cost represents suggested retail cost ($)
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Questionnaire (PAR-Q) (Appendix B) and signed a written informed consent (Appendix
A) prior to participating in the study. Height was measured without shoes using a
stadiometer and weight was also assessed without shoes in light clothing using a
calibrated physician's scale. In addition, each subject's stride length was determined
prior to participation in the study. To determine stride length, subjects were asked to take
20 strides at their normal walking pace on an outdoor track. The total distance was
divided by 20, to calculate average stride length. Physical characteristics of the subjects
are presented in Table 2.
The subjects then took part in a series of walks around a 400-m outdoor track.
Pedometer placement was standardized by placing it on the belt or waistband, in the mid
line of the thigh, consistent with the manufacturers' recommendations. Pedometers with
a variable sensitivity switch (OM, OR) were always placed in the middle setting.
Devices of the same model were worn on both the right and left sides of the body while
the subject walked a lap around the 400-m track. Then, two other devices of the same
model were tested during a subsequent lap around the track to determine intra-model
reliability. This procedure was repeated until 4 pedometers representing each of the 10
models were tested. The actual steps taken were determined by a researcher using a
hand-tally counter. The researcher walked behind the subj ect to avoid influencing the
subject's pace. Each subject walked at his/her own normal walking speed and the
amount of time it took to complete the lap was measured in order to calculate walking
speed. The testing took place over the course of one to four days and the subjects wore
the same pair of shoes for all trials.
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Table 2. Physical characteristics of subjects
. Males
34.7±1 2.6 (22-55)
A ge (yrs)

Females
43 . 1 ±1 9.9 (22-69)

Height (cm)

1 82.4±4,3 (1 75-1 88)

1 65 .0±6 .6 (1 57.5-1 78)

Weight (kg)

92.5±1 5.0 (74.5- 1 I 7.3)

69.3±1 2.5 (5 3.2-90.9)

BMI (kg·m·2)

27.7±4,0 (22 .2-33 .6)

25.5±4,9 (1 8 .6-32. 1 )

Stride length (m)

.79±,07 (.70-.90)

.71±.08 (.60-.85)

Values are mean ± SD (range)
BMI = Body Mass Index
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Statistical Analysis
All analyses were performed using SPSS 1 1 .0.1 for Windows (SPSS Inc.,
Chicago IL). For all analyses, an alpha of 0.05 was used to denote statistical
significance. A 2-way repeated measures ANOVA (model x side) was used to assess
differences between pedometers worn on the right and left sides of the body and to
determine if significant differences existed between pedometer models. Paired t-tests
were used to determine if the pedometer-estimated steps were significantly different from
the actual steps taken. Cronbach's alpha was used to assess the intra-model reliability
among pedometers of the same model. An alpha value of 0.80 was used to denote
statistically significant intra-model reliability (12).
Bland-Altman (5) plots were constructed to show the dispersion of the individual
pedometer error scores around zero. This is a widely accepted technique to show the
accuracy of biomedical devices (27). In this manner, the mean error score can be
illustrated and the 95% prediction interval (i.e., 95% confidence interval for the
individual observations) can also be shown. Individual error scores that have a tight
prediction interval around zero signify a more accurate device.

Results

The average self-selected walking speed was 96.5 m-min- 1 and ranged from 77.3
to 1 1 4.9 m-min- 1 • There was no significant difference (P>0.05) between pedometers
worn on the right and left sides of the body. However, there was a significant difference
(P<0.05) among the 1 0 pedometer models. To determine accuracy, an error score (actual
steps minus pedometer steps) was computed and compared to zero. Individual error
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scores of zero would indicate that there was no difference between the estimated and
actual steps taken, while negative scores represent overestimations and positive scores
represent underestimations. Figure 1 displays the mean error scores between the actual
steps taken and the pedometer-measured steps. The OR significantly overestimated the
actual number of steps taken {P<0.05). The SL330 significantly underestimated the
actual number of steps {P<0.05). The remaining pedometers had mean values that neither
over- nor under-estimated the true number of steps taken. However, as we will show,
three models {NL, DW, KZ) were clearly more accurate than the other models.
Table 3 displays the mean error scores and the 95% prediction intervals. Figures
2-4 show the Bland-Altman plots for various pedometer models. For convenience, theay
axes are standardized to highlight the differences in accuracy between pedometers. The
NL, DW, and KZ models were exceptionally accurate, having 95% prediction intervals
that were within ± 17 steps (out of an average of 513) from zero. The WL, SK, SL345,
FR, and OR were moderately accurate, having 95% prediction intervals that were within
± 100 steps from zero. Finally, the OM and SL330 were the least accurate, having 95%
prediction intervals that were within ± 1 88 steps from zero.
As shown in Table 4, the intra-model reliability (among 4 pedometers of a single
model) was >0.80 in all pedometers with the exception of the SL330. The intra-model
reliability was exceptionally high (>0.99) in the KZ, OM, NL, and the DW. However,
despite high reliability, the OM had poor accuracy.
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Figure 1 . Mean error scores (Actual - Pedometer) ± SE in number of steps during a 400-m track walk at self-selected speeds *
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Table 3. Error scores (Actual -Pedometer) in number of steps during a 400-m track
walk at self-selected speeds.
Pedometer
Mean
SD
95% Prediction Interval

FR

8.0

42.6

(93.1, -77.2)

KZ

-.2

1.5

(2.7, -3 .2)

NL

-.5

2.1

(3 .7, -4.6)

OM

19.0

84.5

(188.1, -150.1)

OR

-13.3 *

27.6

(41.9, -68.6)

SL330

24.7*

70.5

(165.7, -116.4)

SL345

-6.0

37.2

(68.4, -80.3)

WL

2.6

40.0

(82.6, -77.4)

SK

4.8

31.5

(67.8, -58.2)

DW

-.1

8.4

(16.7, -16.9)

SDe= Standard Deviation
Negative scores correspond to overestimations and positive scores represent
underestimations of actual steps taken.
* P<0.05

92

500

Yamax SW-70 1

400
....
�

300

�

200

I

�
.....
�
.....

<

1 00

D

0
- 1 00
-200
400

600

500

700

(Actual Steps + Pedometer)/2

Figure 2. Representative Bland-Altman plot for the Yamax Digi-Walker SW-701 (DW)
which was one of the three most accurate pedometers. Solid horizontal line = mean error
score, dashed linesa= 95% prediction intervals (i.e., 95% Confidence Intervals of the
individual observations).
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Figure 3. Representative Bland-Altman plot for the Oregon Scientific PE3 16CA (OR)
which was among the four moderately accurate pedometers. Solid horizontal line = mean
error score, dashed linese= 95% prediction intervals (i.e., 95% Confidence Intervals of the
individual observations).
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dashed lines = 95% prediction intervals (i.e., 95% Confidence Intervals of the individual
observations).
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Table 4. Intra-model reliability for each of the 1 0 different pedometer models.
Chronbach' s Alpha
Pedometer
.90
Freestyle Pacer Pro
Kenz Lifecorder

.998

New Lifestyles NL-2000

.995

Omron HJ- I 05

.991

Oregon Scientific PE3 16CA

.924

Sportline 330

.76

Sportline 345

.87

Walk4Life LS2525

.885

Yamasa Skeletone

.935

Yamax Digi-Walker SW-70 1

.992
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Table 5 displays the mean difference in actual distance walked and the
pedometer-calculated distance. Negative scores represent overestimations and positive
scores indicate underestimations by the pedometer. There were significant differences
(P<0.05) in five of the six pedometers that calculated distance, with the SL345
approximating distance more closely than all other models. To determine accuracy in
calculating distance, the estimated distance from the pedometer was subtracted from the
actual distance walked and this difference score was compared to zero.

Discussion
.In the current study, eight of the ten pedometers tested yielded mean values that
were not significantly different from the actual steps taken at self-selected walking
speeds. However, the KZ, NL, and DW were the only pedometers accurate to withine±
3% of the actual steps taken, 95% of the time. These three pedometers differed from the
actual steps taken by less than 17 steps during a 400-m walk (totaling about 513 steps).
Interestingly, these pedometers are all made in Japan, and they all met the Japanese
Industrial Standard set by the Ministry of Industry and Trading regulations (7), which
requires less than a three percent margin of error (3 steps out of 100). The intra-model
reliability for the KZ, NL, and DW was also very high (>0.99), suggesting adequate
quality control and tight manufacturing tolerances. These pedometers would appear to be
suitable for use in research studies.
Four of the other pedometers (WL, SK, SL345, FR) had moderate accuracy.
They displayed values that were withine± 20% of the actual steps taken, 95% of the time.
These four models predicted the actual steps to within ± I 00 steps during a 400-m walk.
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Table 5. Error scores (Actual - Pedometer) in distance (m) during a 400-m track walk at
self-selected speeds.
Pedometer
Mean
Std. Error
95% Confidence Intervals
FR

29 *

8

( 11, 47)

OM

37 *

16

(4, 70)

OR

75 *

10

(55, 94)

SL345

12

8

(-6, 30)

WL

33 *

8

( 17, 50)

DW

25 *

6

(12, 37)

Negative scores correspond to overestimations and positive scores represent
underestimations of actual distance walked * P<0.05.
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Three pedometer models were judged to be unacceptable under the conditions in which
they were tested. The OR consistently tended to over-estimate the actual number of
steps, possibly due to a high sensitivity for recording steps. As a result, the OR
significantly over-estimated the mean number of steps (P<0.05). The SL330 and OM
were the least accurate pedometers; they displayed values that were within ± 37% of the
actual steps taken, 95% of the time. These two models predicted the actual steps to
withina± 188 steps during a 400-m walk. Only the SL330 significantly under-estimated
the mean number of steps taken. However, in both of these pedometers, there was a
tendency to grossly underestimate steps, particularly in obese subjects (BMIa::::: 30 kg-m-2).
Thus, these pedometers would be poor choices for use with obese individuals.
There have been conflicting results regarding pedometer accuracy in obese
individuals (BMI 2:30 kg·m-2). Shephard et al. (18) reported that the Sportline pedometer
was less accurate in obese subjects compared with non-obese subjects as evidenced by
greater mean absolute error scores in the obese. However, Swartz et al. (19)
demonstrated that the Yamax SW-200 pedometer was accurate in lean, overweight, and
obese subjects. Their results are consistent with those in the current study in showing
that the Yamax SW-701 was accurate over a wide range of BMI's ( 18.6-33.6 kg·m-2).
(These two models use the same internal mechanism for recording steps; they differ only
in the functions that are displayed). Some other pedometers (OM and SL330) grossly
underestimated steps taken by obese subjects. It should be noted, however, that the OM
was accurate in individuals with both normal BMI's ( 18-24.9 kg·m-2) and those classified
as overweight (25-29.9 kg-m-2). It is possible that in obese individuals, especially those
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with a significant amount of abdominal fat, the angle of the pedometer when clipped to
the belt or waistband compromises its ability to count steps accurately.
Although the accuracy of pedometers for assessing distance was also examined,
the results should be interpreted with caution. To calculate distance, the following
formula is used:
Distancea= steps x stride length
Pedometer models differ in the precision with which stride length can be entered. For
example, some pedometers allow the operator to input stride length to the nearest inch,
while others only allow stride length to be input to the nearest 0.25 ft. Furthermore, only
one stride length can be programmed into a pedometer, so if a subject changes his/her
stride length after the calibration procedure, the distance estimated will be inaccurate.
For most pedometers, distance was underestimated because the subjects had longer
strides (and thus took fewer steps) during the 400-m track walk than in the 20-step
calibration procedure. The SL345 was the only pedometer that did not significantly
underestimate distance. However, this is because the SL345 overestimated the number of
steps taken. Since most researchers choose to report pedometer data as steps, it would be
inappropriate to conclude that the SL345 is the most accurate pedometer.
Recent U.S. physical activity recommendations have encouraged Americans to
accumulate at least 30 minutes of moderate physical activity on most, preferably all, days
of the week (14,26). Dr. Hatano of Japan has proposed an alternative recommendation.
He believes that taking I 0,000 steps per day would be effective for cardiovascular disease
prevention (7). Hatano has found that increased ambulatory activity is associated with
lower levels of blood pressure and subcutaneous fat (8). Hatano also estimated that a 60
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kg Japanese male would expend at least 333 kcal/day in walking 10,000 steps per day.
Previous research indicates that this amount (>2000 kcals/wk) appears to be protective
against heart attacks (13). In addition, longitudinal studies have demonstrated that
walking 10,000 steps per day results in improvements in cardiovascular disease risk
factors in sedentary, at-risk populations (11,20).
Electronic pedometers have gained widespread acceptance among physical
activity researchers over the past decade (4) and the use of pedometers has become
increasingly popular with the continued publicity of the 10,000 steps per day
recommendation (9,15). Thus, it is essential that the pedometer display accurate results.
Wilde, et al. (28) showed that_by adding a 30-minute walk to their daily routine, subjects
increased their step counts from 7,220 to 10,030 steps per day. This study indicates that
for sedentary women, including a daily 30-minute walk in their schedule will generally
allow them to meet both physical activity recommendations, suggesting that the two are
roughly equivalent. However, pedometer accuracy can have a significant impact on the
number of steps counted over the course of a day. A study conducted by Tudor-Locke et
al. compared the Yamax SW-200 with the CSA model 7164 actigraph (a research grade
accelerometer) and showed an 1,800 step/day difference between the two types of step
counters (21). It was suggested that this difference is due to variations in the sensitivity
of the two devices. Thus, since 1,800 steps may represent a relatively large portion of a
person's daily step count and because it is possible for two step-counters to differ by this
amount, it is essential that the pedometer accurately report steps taken.
The electronic pedometer has limitations as a research tool (6) including its
inability to provide information related to non-ambulatory activity (i.e., cycling, weight
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training, and swimming). Neverthel�ss, it does have some distinguishing characteristics
that make it useful as a motivational tool for promoting physical activity. First, the
pedometer continuously monitors physical activity whether it is incidental or intentional.
Studies have shown recall of ubiquitous, moderate activities ( e.g., walking) is less
accurate than recall of structured, vigorous activities (3, 16). Thus, a device that is
capable of continuously monitoring ambulatory activity would be beneficial for those
interested in the assessment of physical activity. Second, the pedometer can serve as a
feedback tool, providing immediate information on accumulated ambulatory activity and
serving as a reminder to be physically active. While earlier criticisms of pedometers
included their inability to store data (6), two of the pedometers assessed in this study, the
NL and KZ pedometers are capable of storing up to 7 and 42 days worth of data,
respectively, in one-day epochs. This makes these pedometers an appealing option for
researchers who want to eliminate the potential bias of subjects recording their own data.
This study is in agreement with the study conducted by Bassett et al. in
demonstrating that considerable variation in accuracy exists among pedometers (2).
Likewise, both studies indicated that a Yamax brand pedometer (DW-500 or SW-70 1 )
was one of the best i n regard to its accuracy and reliability. However, other pedometers
that were unavailable at the time of the previous study have been shown to very accurate
and reliable as well (NL and KZ). An ideal objective instrument is one that is low in
cost, easy to administer to large groups, unobtrusive to the subject, · and accurate (6).
While most pedometers displayed mean step scores that were not significantly different
from the actual steps taken at self-selected walking speeds, some were distinctly better
than ot�ers as indicated by individual error scores that had a tight prediction interval
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around zero. Due to the variation that exists among pedometers in regard to the
manufacturing specifications, mechanism and sensitivity of each device, not all
pedometers count steps accurately. Thus, it is important for researchers who use
pedometers to assess physical activity to know the accuracy and reliability of their
instruments.
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PARTeIV

PEDOMETER MEASURES OF FREE-LIVING PHYSICAL ACTIVITY:
COMPARISON OF 13 MODELS

1 08

Abstract
Purpose : The purpose of this study was to compare the step values of multiple brands of

pedometers over a 24-hour period. The following 13 electronic pedometers were
assessed in the study: Accusplit Alliance 15o10 (AC), Freestyle Pacer Pro (FR), Colorado
on the Move (CO), Kenz Lifecorder {KZ), New-Lifestyles NL-2000 (NL), Omron HJI 05 (OM), Oregon Scientific PE3 16CA (OR), Sportline 330 (SL330) and 345 (SL345),
Walk4Life LS 2525 (WL), Yamax Skeletone EM- 180 (SK), Yamax Digi-Walker SW200 (YX200) and the Yamax Digi-Walker SW-70 1 (YX70 1). Methods: Ten males
(39.5 ± 16.6 yr), (mean ± SD), and ten females (43.3 ± 16.6 yr) ranging in BMI from 19 .8
to 35.4 kg·m·2 wore two pedometers for a 24-hour period. The criterion pedometer
(YX200) was worn on the left side of the body and a comparison pedometer was worn on
the right. Steps counted by each device were recorded at the end of the day for each of
the thirteen pedometers. Results: Subjects took an average of 9,244 steps·d· 1 • The KZ,
YX200, NL, YX70o1 and SL330 yielded mean values that were not significantly different
from the criterion. The FR, AC, SK, CO, and SL345 significantly underestimated steps
(P<0.05) and the WL, OM, and OR significantly overestimated steps (P<0.05) when
compared to the criterion. In addition, some pedometers underestimated by 25% while
others overestimated by 45%. Conclusion: The KZ, YX200, NL, and YX70o1 appear to
be suitable for most research purposes. Given the potential for pedometers in physical
activity research, it is necessary that there be consistency across studies in the
measurement of "steps per day".
Key Words: steps, step counter, 24-hours, motion sensor, walking
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Introduction

The objective quantification of physical activity is a challenge to those involved .
in research and practice. Traditionally, physical activity has been assessed using
questionnaires, but there are limitations in subjects' recall ability, especially for
ubiquitous, light- or moderate-intensity activities (9). Thus, there has been interest in
using objective monitors to record physical activity.
Pedometers are a type of motion sensor that are low-cost, unobtrusive, accurate
(1,4, 11), and their output (steps or distance) is easily comprehendible. Pedometers are
typically worn on the belt or waistband and respond vertical accelerations of the hip
during gait cycles. They provide data on steps and some models estimate distance
traveled and energy expenditure. Although pedometers measure ambulatory activity,
they do not capture all types of physical activity (swimming, weight lifting, bicycling,
etc.). Nevertheless, walking is one of the most common forms of activity and is readily
captured by a pedometer. These devices are becoming increasingly popular in physical
activity research on clinical interventions, community-wide interventions, surveillance,
and international comparisons. A recent PubMed search revealed that the number of
studies using pedometers nearly doubled (32 vs. 60) from 1993- 1997 to 1998-2002.
Pedometers have several practical applications. They can be used to: I )
distinguish between individuals who vary based on steps·d- 1 , 2) measure increases in
physical activity with interventions, 3) conduct cross-study comparisons of different
populations, 4) compare time trends in physical activity. In addition, members of the
general public are interested in using pedometers to determine whether they are meeting
step recommendations. However, if the differences in steps between pedometer brands
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are large and a variety of brands are being used, then it becomes impossible to use
pedometers for these purposes.
Pedometer models differ in regard to cost ($10-200) and internal mechanisms.
There are at least three basic types of mechanisms including the spring-suspended lever
arm with metal-on-metal contact, magnetic reed proximity switch, and an accelerometer
type (4, 1 1 ). The first mechanism uses a spring-suspended horizontal lever that moves up
and down in response to the hip's vertical accelerations. This movement opens and
closes an electrical circuit; the lever arm makes an electrical contact (metal-on-metal
contact) and a step is registered. The second type of mechanism is a magnetic reed
proximity switch. This type also uses a spring-suspended horizontal lever arm, however,
with this mechanism a magnet is attached to the lever arm, and it is the magnetic field
that causes two overlapping pieces of metal encased in a glass cylinder (magnetic reed
proximity switch) to touch, resulting in a step being counted. The third type uses an
accelerometer-type mechanism consisting of a horizontal beam and a piezo-electric
crystal. The walking motion generates a sinusoidal curve when vertical acceleration is
plotted against time. This mechanism uses zero crossings of the acceleration vs. time
curve to detect steps.
A second issue is sensitivity, which is related to the internal mechanism, and is a
function of the vertical acceleration "threshold" needed to trigger a step. Previous studies
(1,4, 1 1) have shown that these differences may translate into variations in accuracy
among· pedometer models. Some models have been shown to be accurate over a fixed
distance (1, 1 1) or at a variety of treadmill speeds ( 1,4) compared to direct observation of
steps. However, no study has compared pedometer models under free-living conditions
11 1

over 24 hours. This is an important issue because pedometer output is often reported as
"steps per day".
One of the difficulties in assessing pedometer accuracy under free-living
conditions is the lack of a "gold standard". Although pedometer accuracy can be
assessed by counting steps in controlled laboratory experiments, it is not feasible to
assess pedometer accuracy in this manner over 24 hours. Therefore, it was decided to use
a single pedometer (Yamax SW-200) as the criterion. In controlled laboratory settings, ·
the Yamax SW series pedometers have been consistently shown to be one of the most
accurate (4,11). In addition, the Yamax pedometer is commonly used in applied research
(7,8,13,16). The purpose of this study was to compare the step values of multiple brands
of pedometers over the course of a 24-hour period.

Methods

Pedometers
The criterion pedometer selected for this study was the Yamax SW-200 (YX200).
Th� SW series pedometer has performed very well in previous validation studies. The
SW-701 (which has the same mechanism as the SW-200) consistently gave values within
3% of actual steps taken during a self-paced walk, on an individual basis (10). Moreover,
this pedometer gave mean step counts that were within 1% of actual steps. At walking
speeds ranging from 54 to 107 m-min· 1 , the SW-701 was the only one out of 10 models
that did not differ significantly from actual steps taken (4). Finally the SW-200
pedometer was found to have similar accuracy in normal weight, overweight, and
moderately obese individuals (12).
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Thirteen models of commercially available electronic pedometers were assessed
in this study: Accusplit Alliance 1510 (AC), Freestyle Pacer Pro (FR), Colorado on the
Move (CO), Kenz Lifecorder (KZ), New-Lifestyles NL-2000 (NL), Omron HJ-105
(OM), C!regon Scientific PE316CA (OR), Sportline 330 (SL330) and 345 (SL345),
Walk4Life LS 2525 (WL), Yamax Skeletone EM-180 (SK), Yamax Digi-Walker SW200 (YX200) and the Yamax Digi-Walker SW-701 (YX701).

Participants
Ten male (39.5 ± 16.6 yr) and ten female adults (43 .3 ± 16.6 yr) ranging in BMI
from 19.8 to 35.4 kg·m·2 volunteered to participate in the study. The procedures were
reviewed and approved by the Institutional Review Board (IRB) at the University of
Tennessee. Each subject completed a Physical Activity Readiness Questionnaire (PAR
Q) (Appendix B) and signed a written informed consent (Appendix A) prior to
participating in the study. Height was measured without shoes using a stadiometer and
weight was also assessed without shoes in light clothing using a calibrated physician's
scale. Physical characteristics of the participants are presented in Table 1.

Protocol
All participants wore the Yamax SW-200 (criterion) on the left side of the body
and a comparison model on the right side for a 24-hour period, except when sleeping or
showering. Each subject was tested over thirteen days, and the order of testing was
randomized for the various pedometer models. (On one of these days the YX200 model
was compared to a YX200 on the opposite side of the body to test for left vs. right side
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Table 1 . Physical characteristics of participants.
Women

Men

All Subjects

Age (yr)

(N=lO)
39.5 ± 1 6.6

(N=18)
43.3 ± 1 6.6

Height (cm)

1 8 1 .6 ± 5 .6

1 64.6 ± 7.3

1 73 . 1

Weight (kg)

89.2 ± 1 7.3

66.6 ± 8.6

77.9 ± 1 7.7

BMI (kg·m2)

26.9 ± 4.6

24.6 ± 3 .2

25 .8 ± 4. 1

Steps·daf 1

9525 ± 2349

8963 ± 2466

9244 ± 3727

Values are Mean ± Standard Deviation
BMI = Body Mass Index

1 14

(N=20)
4 1 .4 ± 1 6.3

± 1 0.8

differences.) Previous studies using the same brand of pedometer have shown that there
is no statistically significant difference between pedometers worn on the right and left
sides of the body (1,4, 11). Among the 20 participants, five devices of each model were
tested to provide a more representative sample.
Pedometer placement was standardized by placing it on the belt or waistband, in
the midline of the thigh, consistent with the manufacturers' recommendations.
Pedometers with a variable sensitivity switch (OM, OR) were always placed in the
middle setting. Subjects were instructed to put the pedometers on each morning and reset
each device to zero, with the exception of two models (KZ, NL), which have internal
clocks and reset on their own at midnight. Subjects then wore the pedometers over the
course of the entire day and wrote the values down on a log sheet before going to bed
each night. This procedure was repeated until all thirteen pedometers were compared to
the criterion. The subjects were instructed not to wear the pedometers on Sundays due to
the fact that significantly fewer steps are usually taken on Sundays compared with all
other days of the week (2).

Statistical Analysis
All analyses were performed using SPSS 11.0.1 for Windows (SPSS, Inc.,
Chicago, IL). For all analyses, an alpha of 0.05 was used to denote st�tistical
significance. A difference score (comparison - criterion) was computed and compared to
zero. Difference scores of zero would indicate that there was no difference between the
criterion pedometer and the comparison pedometer. Positive difference scores represent
overestimations and negative scores represent underestimations. A two-way repeated
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measures ANOVA was used to determine if there was a significant difference between
the mean difference scores of various pedometers and to determine if there was a
significant difference in the mean difference scores between genders. Independent t-tests
were used to determine if the comparison models were significantly different from the
criterion.
Bland-Altman (3) plots were constructed to show the distribution of the individual
(criterioni- comparison) scores around zero. This is a standard method to show the
accuracy of biomedical devices (18). In this manner, the mean difference (criterioni
comparison) can be illustrated and the 95% prediction interval (i.e., 95% confidence
interval for the individual observations) can also be shown. Pedometers that have a tight
prediction interval around zero are more accurate.

Results

Subjects took an average of 9,244 steps·d- 1 according to the criterion pedometer.
There was no significant interaction between pedometer model and gender and there were
no significant gender differences (P>0.05). However, there were significant differences
(P<0.05) among the 13 pedometer models. Figure 1 displays the mean difference scores
expressed as a percentage of the steps counted by the criterion pedometer. Table 2
displays mean difference scores, standard deviations, and 95% confidence intervals for
each pedometer model. The FR, AC, SK, CO, SL345 significantly underestimated steps
while the WL, OM and the OR significantly overestimated (P<0.05). Figures 2-4 show
the Bland-Altman plots for various pedometer models. The Oregon Scientific pedometer
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Table 2. Difference scores (comparison - criterion pedometer) in number of steps over a
24-hour period.

PEDOMETER

MEAN

SD

95% CI

95% PI

FR

*

- 2445

2 1 57

-3454, - 1 436

-6672, 1 782

AC

*

- 2 1 89

2697

-345 1 , -926

-7475, 3098

SK

*

- 1 1 61

2279

-2228, -94

-5629, 3307

co

*

- 1042

2 1 46

-2407, -38

-5249, 3 1 64

SL345

*

- 997

1 872

-1 873 , - 1 2 1

-4666, 2673

KZ

- 703

1 537

- 1 422, 1 7

-37 1 6, 23 1 1

YX200 #

- 372

1 685

- 1 1 61 , 4 1 7

-3675, 293 1

NL

206

1 539

-5 1 4, 926

-2809, 3222

YX701

426

1 547

-298, 1 1 49

-2606, 345 7

SL330

443

1 885

-439, 1 325

-325 1 , 4 1 3 7

WL

t

1 099

1 833

24 1 , 1 957

-2493, 469 1

OM

t

2266

30 1 9

853, 3679

-3652, 8 1 83

OR

t

3636

2662

2390, 4882

- 1 5 83, 8854

SD = Standard Deviation
CI = Confidence Interval
PI = Prediction Interval
* Significantly lower than the criterion (P<0.05)
t Significantly higher than the criterion (P<0.05)
# This pedometer is also sold under the names Accusplit AE 1 20 and Walk4Life LS2000
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Figure 2. Representative Bland-Altman plot for the New Lifestyles NL-2000 (NL) which
was one of the five most accurate pedometers. Solid horizontal line = mean error score,
dashed lines = 95% prediction intervals (i.e., 95% Confidence Intervals of the individual
observations).
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Figure 3. Representative Bland-Altman plot for the Freestyle Pacer Pro (FR) which was
among the five pedometers that significantly underestimated steps (P<0.05) compared
with the criterion (P<0.05). Solid horizontal linea= mean error score, dashed linesa= 95%
prediction intervals (i.e., 95% Confidence Intervals of the individual observations).
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Figure 4. Representative Bland-Altman plot for the Oregon Scientific PE3 1 6CA (OR)
which was one of three pedometers that significantly overestimated steps compared with
the criterion (P<0.05). Solid horizontal line = mean error score, dashed linese= 95%
prediction intervals (i.e., 95% Confidence Intervals of the individual observations).
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appeared to overestimate steps to a greater extent at higher step counts. However, this
was an isolated case as other models did not show this type of systematic error.

Discussion

In the current study, five (KZ, YX200, NL, YX70 1, SL330) of the thirteen
pedometers tested yielded mean values that were not significantly different from the
criterion. Five (FR, AC, SK, CO, SL345) pedometers significantly underestimated steps
and three (WL, OM, OR) significantly overestimated steps, compared to the criterion
(YX200).
The statistical power in the present study was adequate to detect a 10% difference
among pedometer brands. This roughly coincided with what we considered to be a
meaningful difference. For research purposes, we suggest using one of the models that
did not significantly differ from the criterion. The pedometers that met this standard are
the KZ, YX200, NL, YX70 1, and SL330. However, given the fact that statistical
significance is a function of sample size (15), some emphasis should be placed on
practical significance. Thus, we suggest that the CO and SL345, which were
significantly different from the criterion but had mean values within 10% of the criterion
would be suitable choices for physical activity promotion purposes.
The following pedometer determined steps per day activity classifications have
been proposed: <5,000 sedentary, 5000-7,499 inactive, 7500-9,999 somewhat active,
�10,000 active (17). Having standardization among pedometer brands is necessary to
ensure that such a classification scheme for activity status is meaningful. If a pedometer
yields mean scores that are not within ± 10% of the criterion, the risk of misclassification
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increases, making it difficult to compare results across studies. In addition, given that the
same pedometer model on the right and left hip can differ by 5%, this suggests that an
acceptable difference of less than 10% may be too strict. It is important to note that an
acceptable difference of 10% applies only to free-living conditions. Laboratory type
validations must be held to a higher standard as suggested in previous publications (4, 11 ).
Schneider et al. ( 11) previously showed that the KZ, NL, and YX70 1 were the
most accurate pedometers at counting steps during a 400-m track walk at a self-selected
pace. These three pedometers are all made in Japan and they all met the Japanese
Industrial Standard set by the Ministry of Industry and Trading regulations (5) which
requires less than a three percent margin of error (3 steps out of 100). Interestingly, these
same three devices (KZ, NL, and YX70 1) were among the five pedometers that were not
significantly different from the criterion (YX200) in the present study.
Crouter et al. (4) also showed that the KZ, NL, and YX70 1 were among the most
accurate pedometers at counting steps on the treadmill at speeds ranging from 54 to 107
mmin-1 • These three pedometers, along with the WL, showed acceptable accuracy
(recording at least 88% of actual steps) at a slow speed (54 mmin- 1 ) and thus were
considered a good choice for research studies. In that study, these same three pedometers
were among six that gave mean values within ±1 % of the actual steps taken at 80 mmin· 1
and above.
There are four plausible explanations for the step counting discrepancy that exists
among pedometer models. First, models may differ in their vertical acceleration
threshold required to trigger a step. This feature is related to the internal mechanism of
the device, which has been described in a previous publication ( 1 1). Those devices that
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�----------------------------------------are highly sensitive compared to the criterion model are prone to overestimate steps while
those that are less sensitive would likely underestimate steps. The Yamax SW-200
requires an acceleration :::0.35 g to register a step (16). Tudor-Locke et al. ( 16) compared
a pedometer (YX200) and the CSA model 7 164 accelerometer/step counter over a 24hour period and found a significant difference in mean step counts with the YX200
counting 1,845 fewer steps per day than the CSA. This difference was attributed to the
CSA' s lower vertical acceleration threshold required to record a step compared with the
YX200 (0.30 g vs. 0.35 g). Although the lower threshold of the CSA makes it more
likely to capture steps at slower walking speeds, it is also apt to detect non-ambulatory
activity such as twisting, fidgeting, and bending as well as mechanical vibration (e.g.,
motor vehicle travel) (7). Second, some pedometers (FR, AC, SL345) are programmed
to only begin recording steps after four consecutive steps have been taken. For example,
if an individual took just four steps and then stopped, the steps would not be counted.
However, if he took five or more consecutive steps, each step would be counted (the first
four steps do not appear on the output screen but the fifth step registers as _a five and
every step is counted individually thereafter). This feature would logically result in an
underestimation in steps when compared with a device that counts every step regardless
of whether or not they were taken in succession. Third, some devices may be more
accurate than others in overweight or obese subjects. In an individual with a significant
amount of abdominal obesity, the pedometer may not be vertically aligned resulting in
decreased accuracy (11). Finally, one device (OR) has been shown to frequently double
count steps (1 1), which explains the overestimation in this study.
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Previous studies have shown that waist-mounted pedometers gave mean values
within ±12% at speedso� 80 mmin- 1 (1,4) although they tend to underestimate steps taken
at slower walking speeds. A gait laboratory study found that the self-selected walking
speed of 200 healthy adults averaged 84 m·min- 1 (14). Taken together, this might lead
one to conclude that most pedometers would yield fairly similar values (steps per day) in
free-living adults. However, the present study found large mean error scores between
pedometers, ranging from an underestimation of 25% to an overestimation of 45%, for
24-hour data. This suggests that a large percentage of steps taken throughout the day
might be accumulated at slower speeds or in light activity. For future studies, we
recommend the selection of a pedometer model that compares closely with the criterion
model used in the current study. This would help to ensure standardization of free-living
pedometer data.
Hatano (5) has proposed that taking 10,000 steps per day would be effective for
cardiovascular disease prevention. He estimates that a 60 kg Japanese male would
expend at least 333 kcal per day in walking 10,000 steps. Earlier research indicates that
this amount (>2000 kcals per wk) appears to be protective against heart attacks (9).
Alternatively, Hill has proposed that weight gain could be eliminated by some
combination of increasing energy expenditure and decreasing energy intake by 100 kcal
per day (6). He notes that energy expenditure can be increased by 100 kcal per day by
walking an extra mile each day. Hill states that "Walking a mile, whether done all at
once or divided up across the day, burns about 100 kcal, which would theoretically
completely abolish the energy gap and hence weight gain for most of the population. A
mile of walking for most people is only about 2,000 to 2,500 extra steps . . . " (6). Whether
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one's goal is to take 10,000 steps per day or to increase normal daily walking by 2,000
steps per day, it is essential that the pedometer counts are standardized. In this study,
there were several individual occasions where the comparison pedometer gave values that
under or overestimated steps by 35 to 60%, respectively. These inconsistencies in
pedometer-estimated steps would make it difficult to measure progress towards meeting
various daily step goals.
In conclusion, the present study shows that there are differences between models
in pedometer measures of free-living physical activity. Five pedometers appear to give
similar values for steps per day compared to the criterion (YX200). However, one of
these (SL330) was shown to be unreliable in a previous study (11), and therefore cannot
be recommended. The remaining four pedometers (KZ, YX200, NL, and YX701) seem
to be suitable for applied physical activity research. In order to standardize results across
studies, researchers should use one of these pedometers or demonstrate the equivalence
of a different pedometer using a similar research design. Given the increasing use of
pedometers in physical activity research, it is imperative that there be consistency across
studies in the measurement of "steps per day".
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PARTeV

EFFECTS OF A 10,000 STEPS PER DAY GOAL
IN OVERWEIGHT MEN VS. WOMEN

1 30

Abstract
Purpose: The purpose of this study was to compare the effects of a 10,000 steps per day

exercise prescription on body composition, cardiovascular risk factors and adherence in
overweight men vs. women. Methods: 20 men (48 ± 6 yrs) (meane± SD) and 37 women
(46 ± 8 yrs) who were overweight or obese participated in a 10,000 steps per day
intervention. Body weight, body mass index (BMI), percent body fat, fat mass, fat-free
mass, waist circumference, hip circumference, systolic blood pressure, diastolic blood
pressure, and heart rate were determined at baseline, after 20 weeks and again after 36
weeks. A blood lipid profile was assessed at baseline and after 36 weeks. Participants
were not given any instruction regarding dietary intake. Results : 15 men and 24 women
(68%) completed the 36-week intervention. In response to a 10,000 steps per day
exercise prescription, they increased daily walking from 5,232 to 9,159 steps per day.
Men and women experienced similarly significant improvements in body weight, BMI,
percent body fat, fat mass, waist and hip circumferences, and HDL-C. When the effects
of adherence to the exercise prescription were examined, the adherers significantly
reduced body weight, BMI, percent body fat, fat mass, and waist and hip circumferences
after 36 weeks, whereas the non-adherers experienced little or no change in these
variables. Conclusion: The 10,000 steps per day exercise prescription was effective at
producing weight loss in overweight, middle-aged men and women. These results
suggest that this amount of activity is an effective strategy for weight management in this
population.
Key Words: intervention, pedometer, walking, weight loss, adherence
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Introduction

It is well established that obesity is a major public health problem in the United
States and other developed countries. Current data indicate that the prevalence of
overweight and obesity among U.S. adults is 65.7 and 30.6%, respectively ( 15). The
prevalence of obesity has increased in males and females and across all ages from
NHANES II ( 1976-1980), NHANES III (1988-1994) and the continuous NHANES
(1999-2000) (10). Due to the negative health consequences associated with obesity (38)
and the high annual healthcare costs associated with its treatment (5), it is essential to
develop programs designed to prevent and treat this disease.
Excess body weight and physical inactivity are risk factors for chronic disease and
coronary heart disease mortality (20). It is likely that a decline in physical activity ( 12)
resulting from labor-saving devices (27) has contributed to the obesity epidemic in the
United States. Despite the abundance of literature supporting the health benefits
associated with leading a physical activity lifestyle, 55% of Americans remain either
inactive or insufficiently active (4). As a result, Healthy People 20 10 has placed physical
activity among its leading health indicators which reflect the major public health
concerns of the United States (52). However, debate exists regarding the amount of
activity needed to provide optimal health benefits. This has led to the emergence of
numerous exercise prescriptions and recommendations that encourage participation in
various amounts of activity.
Among the more popular is the 10,000 steps per day goal described by Hatano
(14). It originated in Japan and it is becoming increasingly popular in the United States
(16, 53). However, despite the popularity of this exercise prescription, few longitudinal
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studies have attempted to determine the potential health benefits associated with doing
this amount of activity (36, 48) and none have compared its effects on body weight and
body composition in overweight men vs. women. In addition, it is not yet established
whether 10,000 steps per day is a feasible goal for sedentary, overweight adults.
It is well known that two aspects of energy balance can affect body weight:
energy intake and energy expenditure. A reduction in energy intake is typically more
effective than an increase in energy expenditure at producing short term (<6 months)
weight loss (19, 44, 34). However, obesity treatments utilizing a reduction in energy
intake alone have poor long-term effects, as most dieters regain all of the weight loss
within 2 to 3 years (25, 44). An increase in energy expenditure is another option for
producing weight loss. Studies have shown that exercise interventions without dietary
restriction can result in significant reductions in body weight (36, 39, 41) and this
approach has been shown to be important in long-term maintenance of weight loss (24,
44).
Some studies have indicated that exercise-induced changes in body weight differ
in men vs. women (7, 23, 46). Whether exercise is prescribed with a minimum level of
energy expenditure per session or for a specific time and intensity, men often experience
greater changes in body weight than women following an exercise intervention (7, 18, 23,
46). One study found that 225 minutes of moderate-to-vigorous intensity exercise
consisting of primarily walking was ineffective at producing weight loss in women, but
resulted in a 5.2 kg reduction in body weight in men after 16 months (8). Another study
of similar length found that 2000 kcal of energy expenditure per week, although
inadequate for weight loss in women, resulted in a 5. 1 kg weight loss in men (46).
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Interestingly, in both of these studies, women actually experienced slight, nonsignificant
increases in body weight in response to the exercise intervention.
Despite the presence of an apparent gender effect regarding exercise-induced
weight loss, other studies have shown that exercise can be effective at producing a
significant amount of weight loss in men (29, 39) and women (1 3, 36) in the absence of
caloric restriction. However, given the potential for a gender effect in response to
exercise along with the paucity of studies examining the 1 0,000 steps per day goal, it
would be valuable to compare the responses of men and women to this popular exercise
prescription. Therefore, the purpose of this study was to determine the effects of a
1 0,000 steps per day exercise prescription on body composition, cardiovascular risk
factors and adherence in overweight men vs. women.

Methods

Participants
Fifty-seven sedentary, overweight or obese, middle-aged men and women
between 30-55 years of age volunteered to participate in the study. Participants were not
dieting for weight loss and were relatively weight stable (within 4% of their current body
weight) for the three months prior to the intervention. Inclusion criteria for the
participants were: age between 30-60 years, body mass index (BMI) between
25-45 kgm·2, the ability to follow instructions and record data, and the ability to walk 1
mile without pain or discomfort. The exclusion criteria were: history of myocardial
infarction, angina, stroke, heart failure, or uncontrolled cardiac arrhythmias; resting blood
pressure greater than 1 80 mm Hg systolic and 1 00 mm Hg diastolic; current cigarette
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smoking; exercise exceeding 7,300 steps per day or 90 minutes of moderate intensity
activity per week; currently taking weight loss medications or prescription medication
that may impair physical performance. Volunteers were recruited by flyers posted in
public buildings, newspaper advertisements, community presentations and word of
mouth. Prior to their participation, the study was verbally explained, and each participant
read and signed an informed consent form (Appendix C). The informed consent -form
was approved by the University of Tennessee and the University of Tennessee Medical
Center Institutional Review Boards and included sufficient information to ensure their
knowledgeable consent. A health history questionnaire was completed by all participants
prior to the study to screen for any contraindications to exercise (Appendix D).

Study design
The intervention lasted 36 weeks. The two weeks prior to the intervention served
as a baseline period and data from this phase were used to screen participants to confom
that they were inactive (�7 ,300 steps per day). Participants were instructed not to
change their normal activities during the two-week baseline period. All participants were
given a waist-mounted Digi-Walker SW-200 electronic pedometer (Yamax, Inc., Tokyo,
Japan) along with instructions on the proper use of the pedometer. The Digi-Walker SW
series pedometers have consistently scored among the most accurate in previous
validation studies (6, 42, 28) and are reported to have similar accuracy in normal weight,
overweight and moderately obese individuals (47). Prior to the two-week baseline
period, pedometer accuracy was verified by having each participant take 20 steps down a
straight hallway (50, 5 1 ). They were encouraged to regularly repeat this 20-step test to
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I
confinn pedometer accuracy. The participants were instructed to wear the pedometer
each day during all waking hours, except when taking a shower or swimming. All
participants were asked to record the number of steps per day along with the time the
pedometer was put on and the time it was taken off.
After the baseline period, preliminary measures were obtained. At this point, all
participants were given a physical activity prescription that led up to a goal of
accumulating at least 10,000 steps per day. The first week they were encouraged to take
7,000 steps per day, the second week 8,000 steps per day, the third week 9,000 steps per
day, and by the fourth week they were instructed to walk at least 10,000 steps per day.

Protocol
The study protocol required four visits to the laboratory. The first visit included
an introduction to the study, reading and signing the infonned consent form; completing a
health history questionnaire; and pedometer/activity log distribution and instruction.
Participants were also given a three-day dietary record fonn and instructions for use
(Appendix E). Each participant was asked to complete the dietary record during the
week prior to the second visit. The second visit included anthropometric measurements
(i.e., body composition, girth measurements, body weight and height); resting heart rate
and blood pressure assessment; and a blood lipid profile. The third visit occurred 20
weeks after the start of the intervention. Anthropometric measurements and resting heart
rate and blood pressures measurements were repeated at this time point. A dietary record
fonn with instructions was provided at the third visit and participants were asked to
complete the record and return it for subsequent analysis. The fourth visit occurred at the
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end of the 36-week intervention and included a repeat of all the preliminary
measurements. A dietary record form was mailed out two weeks prior to the fourth visit
with instructions for completion. Blood samples were drawn at the outpatient laboratory
at the University of Tennessee Medical Center and analyzed for �lood lipid content by
Dynacare Tennessee (Knoxville, 1N). All other laboratory measurements were made in
the Applied Physiology Laboratory at the University of Tennessee.

Resting Heart Rate and Blood Pressure
Each participant was asked to sit quietly for five to ten minutes after which resting
heart rate and blood pressure was measured. Heart rate was taken at the radial pulse for
15 seconds and then multiplied by four to determine beats per minute. The heart rate was
taken in triplicate. Blood pressure was measured by the same investigator using a
sphygmomanometer and a stethoscope in accordance with the guidelines provided by the
American Society of Hypertension (1 ). The average of the two closest heart rate and
blood pressure measurements served as the resting values.

Blood Lipid Profile
A 1 O ml blood sample was collected from the antecubital vein following a 12 hour
overnight fast. Following centrifugation, the serum was removed and analyzed by the
colorimetric method (2 reagent format) using the Abbott Aeroset chemistry analyzer
(Abbott Laboratories, Abbot Park, IL). Controls were run daily for all tests and used to
verify system performance and to monitor accuracy and precision.
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Anthropometric Measures
Anthropometric measures included body composition, girth, weight, and height.
Body composition was assessed using whole body plethysmography (BOD POD ® Body
Composition System, Life Measurement Instruments, Concord, CA). The BOD POD
utilizes the inverse relationship between volume and pressure to determine body volume,
which is then used to calculate body density. Using the Siri equation (43), body density
was used to calculate percent body fat. The primary advantage of the BOD POD is that it
determines body density based on air displacement rather than on water immersion and is
therefore, simpler and quicker than hydrostatic weighing (33). In addition, studies have
shown that BOD POD estimates of body composition are not significantly different from
those determined by hydrostatic weighing, which is a widely accepted criterion method
(32). The participants sat inside a sealed chamber wearing a lycra/nylon swimsuit and
swim cap. Body volume was corrected for thoracic gas volume using a prediction
equation based on age, gender, and height (33). Girth measurements were assessed at the
waist (narrowest part of the torso) and the hips (maximal circumference at the buttocks
above the gluteal fold) in accordance with the Anthropometric Standardization Reference
Manual by Lohman, Roche, and Martorell (3). Body weight (kg) was measured using a
calibrated physician's scale (Health-o-meter, Bridgeview, IL), and height (cm) was
measured using a stadiometer (Seca Corp., Columbia, MD), also in accordance with
standard practices (11). Every attempt was made to measure body weight at
approximately the same time of day each time subjects were tested.
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Physical Activity Log
During the screening and intervention periods, participants were instructed to
record the time the pedometer was put on, the time it was taken off, and the total number
of daily steps in a physical activity log each day. Physical activity logs were returned to
the Principal Investigator every other week either by fax or mail.

Dietary Assessment
All participants completed a three-day dietary record at baseline, 20 weeks, and
36 weeks. The dietary record was explained to each participant in detail including how to
properly describe the food item, the amount eaten, and how it was prepared. All items
consumed within the three-day period were recorded by the participant and analyzed
using Nutritionist Pro software (First Data Bank Inc., San Bruno, CA). Analyses were
examined to determine if the participants changed their dietary habits over the
intervention period.

Investigator/Participant Contact
Participants were asked to attend an informational session every other week for
the first two months and then monthly thereafter. The purpose of the informational
session was to confirm that the participant was completing the task asked of them, to
address any questions or comments the participant may have had, and to provide an
educational session on a variety of topics. Participants were also given pamphlets
(HealthPartners, Inc. Minneapolis, MN) that included a description of the health benefits
of walking, motivational tips, and ideas for accumulating steps. Participants were
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encouraged to contact the Principal Investigator by phone or e-mail with questions or
comments regarding the walking program.

Data Analysis

An on-treatment analysis was performed on all participants who completed the
intervention, irrespective of adherence. In clinical settings, the on-treatment analysis is
used to assess change in health variables in response to being given a behavioral or
pharmaceutical prescription. In addition, to determine the physiological efficacy of
taking 10,000 steps per day, a separate analysis was also performed on those participants
who successfully adhered to the exercise prescription. In order to maintain clear
separation of those who adhered to the exercise prescription and those who did not,
acceptable adherence was defined as taking an average of 9,500 steps per day or more
from week 4 to week 36. Most studies assessing this variable typically define acceptable
adherence as attending a large percentage of the exercise sessions (26).
All statistical analyses were performed using SPSS 1 1.5 for Windows (SPSS Inc.,
Chicago IL). For all analyses, an alpha of 0.05 was used to denote statistical
significance. Independent samples t-tests were used to compare the baseline
characteristics between genders. Repeated mea�ures analyses of variance (ANOVA's)
were used to compare the effects of gender and adherence on body weight, body
composition, girth measurements, blood pressure, heart rate, and blood lipid profile in
response to taking 10,000 steps per day for 36 weeks. Correlational analyses were used
to assess relationships between the change in daily step counts (steps·d- 1 ) and the changes
in dependent variables. Paired t-tests were used to assess changes within groups over the
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course of the intervention. A 2 x 2 Chi-Square analysis was used to assess adherence to
the intervention.

Results
One hundred nineteen individuals met the initial criteria based on a telephone
interview. Of these, 57 participants (20 men, 37 women) met all study criteria and
initiated the intervention and 39 (15 men, 24 women) participated for the duration of the
study (Figure 1 ). Among the 3 9 participants who completed the study, 10 men and
10 women were able to adhere to the exercise prescription defined a priori as averaging
9,500 steps per day or more. Participants wore the pedometer for more than 15 hours per
day on average over the course of the intervention. The baseline characteristics of the
participants who completed the first half of the study are presented in Table 1.
Significant baseline differences between men and women were found for height, percent
body fat, fat mass, fat-free mass, hip circumference, and HDL-C. A chi-square analysis
showed that adherence to the exercise prescription was not significantly different
between men and women.
Analyses of variance (ANOVA's) were used to examine the effect of gender and
adherence over time. Due to the absence of any significant 3-way interactions (gender x
adherence x time), separate models were run to look at the effects of gender (gender x
time) and adherence ( adherence x time) in response to the intervention. For both men
and women, significant improvements were noted for body weight, BMI, percent body
fat, fat mass, waist circumference, hip circumference, and HDL-C (Tables 2 and 3).
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57 met initial criteria and
initiated the intervention

20emen

37ewomen

17 men participated through
first 20 weeks

25 women participated through
first 20 weeks

JJ
15 men completed the
36-week intervention

24 women completed the
36-week intervention

10 adhered to the
exercise prescription
(2:9,500 steps·d- 1 )

10 adhered to the
exercise prescription
(2:9,500 steps · d- 1 )

Figure 1. Participation Flowchart.
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Table 1. Baseline characteristics of men (ne= l 7) and women (n=25) who
completed at least 20 weeks.
Variable

Men

Women

Age, yrs

45 ± 7

47 ± 6

Steps·d- 1

52 18 ± 1484

5276 ± 1089

Height, cm*

178.7 ± 6.6

166.5 ± 5.9

Weight, kg

105.4 ± 19.3

94.9 ± 16. l

BMI, kg·m·2

32.9 ± 5.0

34.2 ± 5.0

Body fat,e%*

34.8 ± 6.5

Fat mass, kg*

37.7 ± 13.2

48.3 ± 5.2
46.4 ± 1 1.9

Fat-free mass, kg*

68.0 ± 7.9

48 .6 ± 6.3

Waist Circumference, cm

108.6 ± I O . I

102.6 ± 12.8

Hip Circumference, cm*

1 13 .0 ± 10.5

123. 1 e±e1 3 ,3

SBP,emmeHg

127 ± 12

12 1 ± 12

DBP,emmeHg

85 ± 5

83 ± 7

HR, beats·min· 1

70 ± 10

73 ± 1 1

TC, mg·dr 1

182 ± 34

19 1 ± 3 1

Triglycerides, mg·dr 1

147 ± 56

122 ± 64

HDL-C, mg·dr 1 *

39e± 9

54 ± 14

LDL-C, mg·dr 1

1 1 3 ± 30

1 13 ± 26

Data are given as meane± SD.
* Significant difference between men and women (P<0.05)
M (Men), W (Women), BMI (body mass index), SBP (systolic blood pressure),
DBP (diastolic blood pressure), HR (heart rate), TC (total cholesterol),
HDL-C (high-density lipoprotein), LDL-C (low-density lipoprotein)
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Table 2. Dependent variables measured at baseline, 20 weeks, and 36 weeks for
men (n= l 5) and women (n=24) who completed the intervention.
Variable
Weight
(kg)

BMI
(kg·m-2)
Body fat

(%)

Fat mass
(kg)
Fat-free mass
(kg)
Waist Circ.
(cm)
Hip Circ.
(cm)
SBP
(mm Hg)
DBP
(mm Hg)
HR
(beats·min· 1)

Gender
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total

Baseline
1 06.8 ± 1 9.2
94.3 ± 1 6. 1
99. 1 + 1 8.2a
33.1 ± 5. 1
33.9 ± 4.9
33.6 + 4.9a
34.8 ± 6.4
48. 1 ± 5.2
42.9 + 8.6a
3 8 . 1 ± 1 3 .2
45.9 ± 1 1 .9
42.9 + 12.9a
69.0 ± 7.7
48.5 ± 6.4
56.6 + 12.2a
1 09.2 ± 1 0
1 02.5 ± 1 3 . 1
1 05.2 + 1 2.3 a
1 1 3.8 ± 1 0.6
1 22.7 ± 1 3.4
1 1 9.2 + 1 3 .0a
127 ± 1 2
1 20 ± 1 2
1 23 + 1 2
85 ± 5
83 ± 7
84 + 7
70 ± 9
73 ± 1 1
72 + 10

20 weeks
1 03.4 ± 19.6
92.8 + 1 5.2
96.8 1 7.5 b
3 1 .9 ± 5.0
33.4 + 4.7
32.8 4.8 b
32.6 ± 6.7
46.3 + 5 .6
4 1 . 1 9.0b
34.8 ± 1 3 .6
43.5 + 1 0.8
40.2 1 2.5 b
69.0 ± 7.7
49.6 + 6.9
56.9 + 1 1 .9 b
1 06.2 ± 1 0.5
1 0 1 .5 + 1 3 . 1
1 03.3 12.3 b
1 1 0.7 ± 1 0.3
120.4 + 1 2.9
1 1 6.7 1 2.8 b
1 23 ± 1 2
1 25 ± 1 4
1 24 + 1 3
84 ± 5
82 ± 8
83 + 7
71 ± 1 0
73 ± 1 1
73 + 1 1

+

+

+

+

+

+

36 weeks
1 02.6 ± 20.6
92.6 + 1 5. 1
96.4 1 7.8b
3 1 .6 ± 5.3
3 3 .3 + 4.6
32.7 4.9b
3 1 .7 ± 7.2
46.7 + 5.2
4 1 .0 9.4b
33 .8 ± 1 3 .9
43.9 + 1 0.8
40. 1 1 2.9b
69.2 ± 8.0
49.2 + 6.4*
56.8 +1 2.1 ab
1 06.4 ± 1 2.3
1 0 1 .0 + 1 2. 1
1 03 . 1 1 2.4b
1 1 1 . 1 ± 1 2.6
1 20.7 + 1 2.9
1 1 7. 1 1 3.S b
1 26 ± 1 5
1 19 ± 14
1 22 + 1 4
82 ± 6
82 ± 9
82 + 8
71 ± 1 1
72 ± 9
72 + 1 0

+

+
+

+

+
+

Values with different superscripts indicate significant differences within groups
(P<0.05). Pairwise comparisons were done only on total values.
*Indicates a significant difference in the way men and women responded over the
course of the intervention.
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Table 3. Blood lipid profiles measured at baseline and 36 weeks
for men (n=13) and women (n=23) who completed the intervention.
Variable
TC
(mg·dr 1 )

Triglycerides
(mg·dr 1 )
HDL-C
(mg·dr 1 )
LDL-C
(mg·dr 1 )

Gender
Men
Women
Total
Men
Women
Total
Men
Women
Total
Men
Women
Total

Baseline
181 ± 36
190 ± 31
187 + 33
140 ± 52
125 ± 63
130 + 59
40i± 9
53 ± 14
48 + 13a
113 ± 30
112 ± 27
113 + 28

36 weeks
174 ± 38
193 ± 29
186 + 33
135 ± 76
110 ± 59
119 + 66
42 ± 10
56i+ 10
51 12b
105 ± 32
115 ± 25
111 + 27

+

Values with different superscripts indicate significant differences from baseline to
36 weeks (P<0.05). Pairwise comparisons were done only on total values.
Two men and one woman were excluded from the lipid profile analysis due to
changes in cholesterol-altering medication.
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Only the change in fat-free mass differed significantly between men and women in
response to the intervention with the women experiencing a slight but significant increase
in this variable. Figures 2 and 3 show the changes in daily step counts and body weight
among men and women in response to the intervention. Two men and two women were
excluded from the blood pressure and heart rate measurements due to changes in
medications that may alter these variables. Two men and one woman were excluded
from the lipid profile analysis due to changes in cholesterol-altering medication.
A repeated measures ANOVA was also done on all men and women who adhered
to the exercise prescription for the full 36 weeks (data not presented). Again, fat-free
mass was the only variable that responded differently between men and �omen.
Significant improvements were noted for body weight, BMI, percent body fat, fat mass,
waist circumference, and hip circumference.
Due to the lack of significant differences between men and women in the
response to the intervention (except for fat-free mass), an analysis was performed on the
combined group to compare those who adhered to the exercise prescription and those
who did not. At baseline, there were no significant differences between any variables
when comparing the adherers with the non-adherers. A repeated measures ANOVA
showed that the adherers experienced significant improvements in body weight, BMI,
percent body fat, fat mass, waist circumference and hip circumference (Tables 4 and 5).
Little or no changes were seen in the non-adherers, although they did significantly
increase their daily step counts by 2500 steps·d- 1 • Figures 4 and 5 show the changes in
daily step counts and body weight among the adherers and the non-adherers.
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Figure 2: A comparison of changes in daily step counts among men and women
in response to a 10,000 steps per day intervention.
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Figure 3 : A comparison of changes in body weight among men and women in
response to a 10,000 steps per day intervention.
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Table 4. Dependent variables measured at baseline, 20 weeks, and 36 weeks in
adherers (n=20) and non-adherers (n= l 9).
Variable
Weight, kg
Adherers
Non-adherers
BMI, kg·m·2
Adherers
Non-adherers
Body fat,e%
Adherers
Non-adherers
Fat mass, kg
Adherers
Non-adherers
Fat-free mass, kg
Adherers
Non-adherers
Waist Circ, cm
Adherers
Non-adherers
Hip Circ, cm
Adherers
Non-adherers
SBP,emmeHg
Adherers
Non-adherers
DBP,emmeHg
Adherers
Non-adherers
HR, beats·min·1
Adherers
Non-adherers

Baseline

20 weeks

36 weeks

99.8 ± 2 1 . 1 a
95.2 + 1 4.9

97.0 ± 20.5 b
94.6 + 1 3.6

95.3 ± 20.7b
95.5 + 1 3.5

33.5 ± 5 .3 a
32.4 + 4.0

32.5 ± 5 . l b
32.2 + 3 .8

3 1 .9 ± 5 , 1 b
32.5 + 3 .8

40.6 ± 8.7a
44.8 + 8.8 a

3 8 .3 + 8.5b
43.5 9.2b

+

37.4 + 9.2b
44.3 8.7ab

4 1 .0 ± 1 3 .7a
43.0 + 1 2.5 a

37.8 + 1 3 . l b
4 1 e.5 1 1 .e8 b

+

36.3 ± 1 3 .5 b
42.6 + 1 1 .5 a

59. 1 ± 1 2.9
52.6 + 1 0. 8 a

59.5 + 1 2.2
53 .4 1 0.8b

+

59.4 + 1 2.5
53.4 1 0.7b

1 06.7 ± 1 1 .4a
1 00.2 + 1 1 .3

1 04. 7 ± 1 1 .S b
99.7 + 1 1 .9

1 03 .6 ± 1 2.2b
1 00.2 + 1 1 .3

1 1 7.0 ± 1 3 .0 a
1 1 8.7 + 1 2.s a

1 1 4.4 + 1 2.7b
1 1 7.2 1 2.0b

+

1 1 4. 1 + 1 3 .7b
1 1 7. 8 1 2.2ab

1 26 ± 1 4
118 + 10

1 26 ± 1 5
1 22 + 1 2

1 26 ± 1 7
1 1 7 + e1 1

85 ± 7
82e+ 6

84e± 8
82e+ 6

83 ± 9
81 + 7

75 ± 1 2
70 + 1 0

74e± 1 2
72 + 1 0

74 ± 1 1
70e+ 8

+

+

+

Values with different superscripts indicate significant differences (P<0.05) within
groups.

1 49

Table 5. Blood lipid profiles measured at baseline and 36 weeks in
adherers (n=16) and non-adherers (n= l 7).
Variable
TC, mg·dr 1
Adherers
Non-adherers
Triglycerides, mg·dr1
Adherers
Non-adherers
HDL-C, mg·d1· 1
Adherers
Non-adherers
LDL-C, mg·dr1
Adherers
Non-adherers

Baseline

36 weeks

192 ± 37
182 + 30

187 ± 38
187 + 32

143 ± 67
120 + 50

131 ± 86
108 + 44

46e± 13a
48 + l l a

50 + 14b
52 10b

117 ± 29
109 + 28

111 ± 28
113 + 30

+

Values with different superscripts indicate significant differences (P<0.05) within
groups.

150

1 1 000 -,-----------------------

1 0000

9000

i;'

'O

�

·· - . . ...

8000

7000

.

.. . . . ..

. . . .. . . .

-·

-Adherers
· · + · · Non-adherers

6000

5000

4000

+---.------.----.---------------..---!
0

1 -4

5-8

9-1 2

1 3-1 6 1 7-20 21 -24 25-28 29-32 33-36
Weeks

Figure 4: A comparison of changes in daily step counts among the adherers and
non-adherers in response to a 10,000 steps per day intervention.
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Partial correlations were used to assess the relationship between the increase in
daily walking over 36 weeks and the change in dependent variables while controlling for
changes in energy intake and initial body weight. There were significant correlations
noted between the increase in daily step counts (steps·d- 1 ) and the changes in body weight
(r = -.42), BMI (-.42), hip circumference (-.41), percent body fat (-.44), and fat mass
(-.45). A marginal partial correlation (P<0.10) was found between the increase in daily
step counts and the change in waist circumference (-.35). Pearson correlations were used
to assess the relationship between the increase in daily walking and the change in
dependent variables over the course of the intervention. A significant correlation was
found between the increases in daily step counts and HDL-C (.45).
No statistically significant differences were found between men (2498, 2315,
271 1 kcal at baseline, 20 weeks, and 36 weeks) and women (2 194, 209 1, and 1993 kcal at
baseline, 20 weeks, and 36 weeks) for total energy intake or macronutrient composition
(carbohydrate, protein, and fat) across the 36-week intervention. In addition, no
significant within gender changes were noted in any of these dietary variables. Likewise,
no statistically significant differences were noted between the adherers and non-adherers,
nor did either group significantly change any of the abovementioned dietary variables
over the course of the study.
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Discussion

On-treatment
The on-treatment analysis showed that overweight men and women given a
10,000 steps per day exercise prescription experienced significant improvements in body
weight, BMI, percent body fat, fat mass, waist and hip circumferences, and HDL-C.
The only factor that responded differently between genders was fat-free mass. However,
the change in fat-free mass in both genders was very small (<1 kg) and is unlikely to be
considered clinically significant. These findings suggest that a 1 0,000 steps per day
program is effective at improving body weight and body composition in previously
sedentary, overweight adults.
We ·recognize that statistical significance is largely a _function of sample size (49).
Based on the difference in weight loss between men and women, it would have taken 1 04
individuals (52 men and 52 women) to detect a significant difference in this variable
(80% power). Nonetheless, this study indicates that the gender difference in response to
this exercise intervention was not as large as what some previous studies have found
since men and women responded to a 1 0,000 steps per day goal in a similar manner.
To determine if there was a dose-response relationship between the change in
daily step counts and the dependent variables, a partial correlation was used to compare
the increase in daily walking with the change in all dependent variables after controlling
for baseline body weight along with any change in energy intake over the course of the
intervention. Significant correlations were found between the increase in daily step
counts and the changes in body weight, BMI, percent body fat, fat mass and hip
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circumference. This suggests that the greater the increase in daily walking, the greater
the improvement in body weight and body composition variables.

Adherers vs. Non-adherers
In comparing men who adhered to the exercise prescription to women who
adhered, once again little effect of gender was seen. This suggests that walking 10,000
steps per day is equally efficacious for weight loss in sedentary, overweight men and
women.
Given that men and women responded similarly, a comparison was made between
those who adhered to the exercise prescription with those who did not. Both adherers and
non-adherers significantly increased daily walking (by 5,275 and 2,472 steps·d- 1 ,
respectively). Although the increase in daily walking was significant for both groups,
only the adherers showed significant improvements in body weight, BMI, percent body
fat, fat mass, waist circumference, and hip circumference after 36 weeks. In contrast,
those who did not adhere to the exercise prescription had little or no change in these
variables.
Although no significant differences were apparent in regard to body weight or fat
mass change between men and women in response to the intervention, men tended to lose
a little more weight and fat mass than women. This is partly due to the fact that the men
were heavier than the women, and heavier individuals expend more calories per step.
Thus, for a given increase in daily walking the men would have expended more calories,
which favored the tendency to lose more weight. In addition, men showed a trend
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towards greater adherence to the 1 0,000 steps per day exercise prescription which could
also have been a contributing factor.

Comparison to Literature
An increase in physical activity has long been considered a potential tool for
weight management. Several studies have assessed the effect of walking on body weight
in men or women. Pollock et al. (40) found that a 20-week, moderate-to-high intensity
walking program for 1 60 minutes per week in middle-aged men resulted in a statistically
significant 1 .3 kg of weight loss. Similarly, Moreau et al. (36) showed that adding a
3-km daily walk to the normal activity (4,300 steps·d- 1 increase) of postmenopausal
women also resulted in a significant weight loss of 1 .3 kg after 24 weeks. Other walking
studies have also noted weight loss in both genders ( 1 3 , 29, 35, 37). However, not all
studies have found walking to be effective at producing weight loss. Hinkleman and
Nieman ( 1 7) showed that a 1 5-week, moderate intensity walking program, 5 days per
week for 45 minutes per session did not result in significant reductions in body weight or
fat mass in overweight women. Snyder et al. (45) also found that a 32-week walking
program for 150 minutes per week was not sufficient to produce significant changes in
body weight or body composition in overweight females.
Studies that have evaluated the gender effect have shown that men lose more
weight than women in response to an exercise intervention (2, 7, 23, 46). Donnelly et al.
(7) showed that after 16 months of moderate-intensity exercise that progressed up to
225 minutes per week, only men lost a significant amount of body weight and fat mass.
Men lost 5.3 kg of body weight and 5.0 kg of fat mass after 9 months, at which point
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weight loss leveled off and did not change significantly for the remainder of the study. In
contrast, women showed a trend towards an increase in body weight (0.6 kg) and
decrease in fat mass (-0.2 kg). Snyder-Heelan et al. (46) also found that men were more
successful in regard to weight loss than women following a 66-week intervention. In this
study, exercise was adjusted to result in 400 kcal of energy expenditure per session, 5
days per week. Similar to the findings of Donnelly et al. (7), men in this study lost 5 .1 kg
of body weight while women had a slight but statistically insignificant increase in body
weight (0.8 kg).
The current study shows close agreement with the findings of both Donnelly et al.
and Snyder-Heelan et al. in regard to the change in body weight in men, but differs with
regard to the changes in body weight in women. However, the current study is in
agreement with the findings of Moreau et al. (36) concerning the amount of weight loss
in women. The current study found that both sedentary, overweight men and women lose
weight if they walk 10,000 steps per day. It is unclear why some previous exercise
interventions failed to produce weight loss in women. Possible explanations are that, in
some studies, women expended less energy (due to lower adherence or smaller body
size), increased their energy intake to compensate for the increase in exercise energy
expenditure, or they unintentionally decreased their habitual physical activity.

Lipid Profile and Blood Pressure
High-density lipoprotein values increased similarly in both men and women and
in the adherers and non-,adherers. In addition, there was a significant correlation between
the increase in daily walking and the increase in HDL-C. Consistent with other findings
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(31 ), the women in this study had significantly higher baseline HDL-C levels than the
men. However, unlike other studies, women were not more resistant than men to
exercise-induced changes in HDL-C ( 1 7, 30).
There were no significant changes in blood pressure or heart rate among men and
women or among the adherers and non-adherers. This is due to the fact that most of the
participants had initial resting blood pressure values that were in the normal range. Thus,
a lack of change in these variables is consistent with finding that blood pressure changes
are likely to be minimal in normotensive individuals (9, 2 1 , 22, 40).

Summary
The 1 0,000 steps per day exercise prescription was effective at increasing daily
walking and resulted in significant improvements in .body weight, BMI, percent body fat,
fat mass, waist circumference, hip circumference, and HDL-C in overweight, middle
aged men and women. In addition, those who adhered to the exercise prescription
experienced significantly greater improvements in body weight and body composition
when compared with those who did not adhere. These results suggest that the 10,000
steps per day exercise prescription is an effective tool for weight management and should
be considered as a strategy for dealing with the current obesity epidemic.
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INFORMED CONSENT FORM
The Validation of Electronic Pedometers

Investigator: Patrick L. Schneider
Address:
The University of Tennessee
Department of Health, Safety, and Exercise Science
1914 Andy Holt Ave.
Knoxville, TN 37919
Telephone: 865-974-5091
Purpose
You are invited to participate in a research study. The purpose of this study is to examine
the use of electronic pedometers to measure steps taken, distance walked, and caloric
expenditure. If you give your consent, you will be asked to participate in one part of the
study. The section checked below is the part of the study you are volunteering for.
Before exercising, you will be given a brief questionnaire to determine your health status
and you will be measured for height and weight in the laboratory.
Procedures
Part 1. Course validation - You will take 20 strides and the total distance covered
will be divided by 20 to determine stride length. You will then be asked to walk
around a 400 meter outdoor track a total of 2 times for each pedometer of the
same brand. A total of 12 different brands of pedometers will be tested.
Therefore, you will be asked to walk around the 400 meter track a total of 24
times which is equivalent to 6 miles. A researcher will accompany you on each
walk, manually counting each step. The testing will take place over the course of
1-5 days and will require a total of about 2-4 hours of your time.
__ Part 2. Effects of walking speed - You will be asked to walk on the treadmill at
2.0, 2.5, 3.0, 3.5, and 4.0 mph (5 minutes per stage). The effects of walking speed
on the accuracy of each of the 10 brands of pedometers being tested will be
examined. The testing will take place over the course of 3-5 days and will require
about 4-5 hours of your time. You will be asked to wear a nose-clip and
mouthpiece, and breathe into a device to measure oxygen uptake for each of the
five 25 minute trials you will be asked to complete. The liters of oxygen actually
consumed will be compared against the estimated value from the pedometer. You
will also have your resting metabolic rate measured using the nose-clip and
mouthpiece for 40 minutes on a separate day from the walking trials.
__ Part 3. 24-hour comparisoni- You will be asked to wear a Yamax SW-200
pedometer on one hip and another model on the other for 24 hours and record the
number of steps registered on both pedometers at the end of each day. A
comparison will then be made between the Yamax SW-200 and the comparative
model. A total of 12 pedometers will be compared to the Yamax SW-200,
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which will require a total of 12 days of testing. You will not be asked to do any
activities beyond which you would normally do on any other day. You will be
given instructions on how to use each pedometer and will not be asked to return to
the laboratory until all 12 pedometers have been compared.
Risks and Benefits
There are very few risks associated with moderate exercise. The risks include abnormal
blood pressure responses and heart rhythm disturbances. These risks of participating in
this study are equivalent to the risks of activities requiring moderate exertion (yard work,
light sport activities, etc.) that you engage in during everyday activities. The benefits to
participation include knowledge of your stride length, and exposure to a device that may
provide accurate information about "steps taken" and "distance walked;" You will also
be given information on your resting metabolic rate.
Confidentiality
The information obtained from these tests will be treated as privileged and confidential
and will consequently not be released to any person without your consent. However, the
information will be used in research reports or presentations, but your name and other
identity will not be disclosed.
Right to Ask Questions and to Withdraw
You are free to decide whether or not to participate in this study and are free to withdraw
from the study at any time.
Before you sign this form, please ask questions about any aspects of the study which are
unclear to you.
Consent
By signing this paper, I am indicating that I understand and agree to take part in this
research study.

Date

Your signature

Date

Researcher's signature
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Physical Activity Readiness Questionnaire (P AR-Q)
Regular physical activity is fun and healthy, and increasingly more people are starting to
become more active every day. Being more active is very safe for most people.
However, people should check with their doctor before they start becoming much more
physically active.
If you are planning to become much more physically active than you are now, start by
answering the seven questions in the box below. If you are between the ages of 15 and
69, the PAR-Q will tell you if you should check with your doctor before you start. If you
are over 69 years of age, and you are not used to being very active, check with your
doctor.
Common sense is your best guide when you answer these questions. Please read the
questions carefully and answer each one honestly: check YES or NO.
YES NO

1. Has your doctor ever said that you have a heart condition and that
you should only do physical activity recommended by a doctor?

YES ·No

2. Do you feel pain in your chest when you do physical activity?

YES NO

3 . In the past month, have you had chest pain when you were not
doing physical activity?

YES NO

4. Do you lose your balance because of dizziness or do you ever lose
consciousness?

YES NO

5. Do you have a bone or joint problem that could be made worse by
a change in your physical activity?

YES NO

6. Do you know of any other reason why you should not be doing
physical activity?

I have read, understood and completed this questionnaire. Any questions I had were
answered to my full satisfaction.
Name ________________
Signature _______________
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INFORMED CONSENT FORM
TITLE OF STUDY: A comparison of the 1 0,000 steps per day recommendation in
overweight men vs. women: the effects on cardiovascular risk factors and adherence
Investigator:

Patrick L. Schneider, M.S.

Address:

The University of Tennessee
Department of Health and Exercise Science
1 9 1 4 Andy Holt Ave.
Knoxville, TN 37996

Telephone:

865-974-5091

Co-Investigators:

David Bassett, Ph.D.
Kenneth Bielak, M.D.

PURPOSE
You are invited to participate in a research study examining the effects of a 36week walking program on adherence, weight loss and cardiovascular risk factors. This
study will provide information on the relationship between walking 1 0,000 steps per day
and specific health benefits. The research will take place at both the University of
Tennessee and the University of Tennessee Medical Center. This study will begin in the
Summer of 2003 and will conclude in the Spring of 2004 and will involve 1 00
participants.
PROCEDURES
If you choose to participate in this study, you will report to the Applied
Physiology Laboratory, Room 310 in the Health, Physical Education and Recreation
(HPER) building at the University of Tennessee on four separate occasions: prior to the
study to complete necessary paperwork described below (this visit), at baseline, 1 8
weeks, and 36 weeks for the measurement of a variety of health related variables. Each
occasion is expected to last about 1 hour. Prior to any testing, you will complete a
questionnaire regarding your health history, exercise training habits, and your readiness

to adopt a physical activity program. The health history form will be used to ensure that
the testing is safe for you. You will be asked to report to the laboratory in a rested
condition not having consumed food 1 2 hours prior to testing. Your will also be asked to
refrain from alcohol consumption and exercise for 1 2 hours prior to the test. On two
occasions, you will be asked to report to the outpatient laboratory at the University of
Tennessee Medical Center for a blood cholesterol test.
On each of your visits, you will report to the laboratory between 6:00 and
1 0:00 a.m. after a 1 2-hour overnight fast. Your blood pressure and heart rate will be
measured three times while you are sitting in a chair after you have rested quietly for five
minutes. Your body composition will be determined by measuring your height, weight,
waist and hip circumferences, and body fat percentage. Two different techniques
1 75

(Tanita® and Bod Pod®) will be used to assess body fat percentage. The Tanita®, is a
device that is similar in appearance to a bathroom scale. You will be asked to stand on
the "scale" with bare feet, dressed in a swimsuit for approximately one minute. This
device estimates your body fatness by measuring the resistance to a small electrical
current that is passed from the scale through your body. You will not be able to feel the
current and this test is harmless. The Bod Pod®, is a whole body chamber that uses
changes in air pressure within the chamber to determine body volume. Your body
volume will be measured as you sit for approximately 3 minutes in a sealed chamber
wearing a lycra swimsuit. During this time you will be able to breathe normally and. view
your surroundings. Along with your body weight, body volume is used to estimate body
fatness. When you report to the outpatient laboratory at the University of Tennessee
Medical Center, a needle will be inserted into your forearm and a small blood sample (7
cc, about 1 ½ teaspoons) will be taken to be later analyzed for blood cholesterol levels.
The blood will be disposed of immediately after the blood cholesterol measurement is
complete.
You will be given an electronic pedometer to wear throughout the day during the
entire study. You will be asked to record the number of steps shown on the pedometer at
the end of the day for two weeks. This information will allow us to determine your
current average weekly walking distance. You will also be given a three-day dietary
record form and will be asked to record the food and drink that you consume for three
days.
WALKING PROGRAM
After completion of all the baseline measures, you will then be given a
recommendation that leads up to taking at least 10,000 steps per day for 36 weeks. The
first week you will be asked to take 7,000 steps per day. The second, 8,000 steps per day.
The third, 9,000 steps per day. And on the fourth week you will be asked to take at least
10,000 steps per day. You will be asked to walk at a self-selected, comfortable pace. In
order to get at least 10,000 steps per day, you will have to do some walking beyond that
required by your normal daily routine. This additional walking can be accumulated in
several short bouts or can be done all at once. Your walking steps, along with the time
that you put the pedometer on in the morning and the time that you take it off in the
evening will be recorded on a daily log sheet. You will also be asked to attend a one
hour informational session every other week for the first two months and then monthly
thereafter. The informational sessions are intended to allow you to ask questions or make
comments about the walking program and to provide you with educational information
on a variety of health related topics.
RISKS ASSOCIATED WITH PARTICIPATION
The potential risks that may occur while participating in this study are those
associated with any type of exercise: injury to muscles and/or joints, dizziness, headache,
and in very rare instances heart attack. However, these risks are minimal in healthy
individuals, and the investigators are trained to conduct these types of experiments. In
addition to the pain and/or discomfort associated with taking a small blood sample to
determine your blood lipid profile (cholesterol), you may experience some local bruising,
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tenderness and/or an area of infection where blood samples were taken. Trained
technicians will perform the blood sampling technique and sterile procedures will be used
to minimize this risk. In regard to the walking program, you will be walking at a self
selected pace.
BENEFITS ASSOCIATED WITH PARTICIPATION
This study will provide information on the relationship between taking 10,000
steps per day for 36 weeks and specific health benefits in males vs. females. You will
benefit by acquiring valuable information on your current health status including: blood
lipid profile, body composition, and resting heart rate and blood pressure. If you
participate in the walking program, you may obtain some health and fitness benefits by
participating in the walking program and developing a positive exercise habit. You will
also get experience with the pedometer that will provide information on steps taken over
the course of a day.
ALTERNATIVES TO PARTICIPATION
As an alternative to participating in this study, you may choose to not participate.
CONFIDENTIALITY
The information obtained from the tests will be treated as privileged and
confidential and will consequently not be released to any person without your consent.
All the information collected will be coded by a subject number rather than by name and
will be kept in a locked file cabinet by Patrick Schneider. However, the information will
be used in research reports or presentations, but your name and other identity will not be
disclosed.
COMPENSATION AND TREATMENT FOR INJURY
I understand that I am not waiving any legal rights or releasing the University of
Tennessee or its agents from liability for negligence. I understand that, in the event of
physical injury resulting from research procedures the University of Tennessee does not
have funds budgeted for compensation either for lost wages or for medical treatment. In
the unlikely event that physical injury occurs as a result of participating in this study,
financial compensation is not automatically available and medical treatment will not be
provided free of charge. If a physical injury should occur over the course of the study,
immediately notify the primary investigator, Patrick Schneider (see below for phone and
office numbers).
QUESTIONS
If you have questions or concerns at any time during the course of this
investigation or after you complete the study, you may contact Patrick Schneider at (865)
974-5091. Patrick Schneider's office is located in the HPER Building in Room 303. If at
any time during this study, events occur that will impact your ability to participate (i.e.,
you sustain a training injury, you are ill, etc.), you should inform Patrick Schneider
immediately. You may also contact the chairman of the University of Tennessee
Graduate School of Medicine Institutional Review Board at (865) 544-9781 if you have
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any questions about your rights as a participant in this study or your rights as a research
subject.
PAYMENT FOR PARTICIPATION
As a volunteer in this study, you will not receive any payment in exchange for
your participation.
COSTS OF PARTIPATION
There will not be any additional costs to you as a result from participating in this
study.
VOLUNTARY PARTICIPATION
As a volunteer in this study, it is your right to withdraw from this investigation at
any time. If you decide to withdraw from this study, you will in no way be penalized. If
you are unable to adhere to the walking program, you will be asked to continue wearing
the pedometer and continue completing the physical activity log. In addition, you will
also be asked to attend the 18-week and 36-week measurement sessions.
CONSENT
I have read or have had read to me the description of the research study as
outlined above. The investigator or his representative has explained the study to me and
has answered all of the questions I have at this time. I have been told of the potential
risks, discomforts, side effects and adverse reactions as well as the possible benefits of
the study. I freely volunteer to participate in the study. I understand that I do not have to
take part in this study and that my refusal to participate will involve no penalty or loss of
rights to which I am entitled. I further understand that I am free to later withdraw my
consent and discontinue participation in this study at any time. I understand that refusing
to participate later or withdrawing from the study will not adversely affect my subsequent
medical care.

Signature of Research Subject or Legally Authorized Representative

Date

Signature of Witness

Date

Signature of Principal Investigator

Date
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HEALTH HISTORY QUESTIONNAIRE

NAME _____________

DATE _______

DATE OF BIRTH _________

AGE _____

ADDRESS _______________

PHONE NUMBERS (HOME) _____
e-mail address:

(WORK) ______

--------------

When is the best time to contact you? __________________

When is the best time for you to attend a one-hour informational session to be held every
other week for the first two months of the program and then monthly thereafter?
Weekdays: am __ pm __
Weekends: am __ pm __
Please list specific days or times if necessary __________________
Please answer the following questions. This information will only be used for research purposes
and will not be made public. Please answer these questions based on physical exercise in which
you regularly engage. This should not include daily work activities such as walking from one

office to another.

1 . Do you regularly engage in exercise? Yes/No

Ifyes, please describe.

2. On average, how many times per week do you engage in exercise training?

o __ __ 2 __ 3 __ 4 __ s __ 6 __ 1 __
3. On average, how long do you exercise each time?
0- 1 9 minutes ___ 20-40 minutes ___ more than 40___
4. How long have you been exercising at this level?
Less than 6 months
6 - 1 2 months
1 - 2 years
3 or more years
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MEDICAL HISTORY
Past History:
Have you ever been diagnosed with the following conditions? Please check the appropriate
column.
Yes
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

Rheumatic fever
Heart murmur
High Blood Pressure
Any heart problem
Lung Disease
Seizures
Irregular heart beat
Bronchitis
Emphysema
Diabetes
Asthma
Kidney Disease
Liver Disease
Severe Allergies
Orthopedic problems
Hyper- or Hypothyroidism
AIDS
Heparin Sensitivity

No
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

Don't Know
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

Present Symptoms Review:
Have you recently had any of the following symptoms? Please check if so.
Chest Pain
Shorbless of breath
Heart palpitations
Leg or ankle swelling
Coughing up blood
Low blood sugar
Feeling faint or dizzy
Leg numbness

(
(
(
(
(
(
(
(

Do you smoke? Yes/No

)
)
)
)
)
)
)
)

Freq uent Urination
Blood in urine
Burning sensations
Severe headache
Blurred vision
Difficulty walking
Weakness in arm
Significant emotional problem

(
(
(
(
(
(
(
(

)
)
)
)
)
)
)
)

If yes, how many per day? _____

Are you currently trying to lose weight (through diet, exercise, and/or medication)? Yes/No
Are you taking any medications? Yes/No
If yes, please describe: ______________________
On average, how many alcoholic drinks do you consume per week? _______
Can you walk I continuous mile without pain or discomfort? _______
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OTHER INFORMATION
Whom should we noti fy in case of an emergency?
Name
Address
Phone #
I have been given the opportunity to ask questions about any of the above items that were unclear,
and I have answered all questions completely and truthfully to the best of my knowledge.
SIGNATURE

DATE _______
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APPENDIXeE
PARTeV
DIETARY RECORD INSTRUCTIONS
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Dietary Record Instructions

1. Use the Dietary Record Forms provided to record everything you eat or drink for
3 consecutive days - two weekdays and one weekend day.
2. Indicate the name of the FOOD ITEM, the AMOUNT eaten, how it was
PREPARED (fried, boiled, broiled, etc.), and the TIME the food was eaten. If the
item was a brand name product, please include the name. Try to be accurate
about the amounts eaten. Measuring with measuring cups and spoons is best, but
if you must make estimates, use the following guidelines:
Fist is about 1 cup
Tip of Thumb is about 1 teaspoon
Palm of the hand is about 3 ounces of meat (about the size of a deck of
cards)
Tip of Thumb is about 1 ounce of cheese
3. Try to eat what you normally eat and record everything. The project will only be
useful if you are HONEST about what you eat. The information you provide is
confidential.
4. MILK: Indicate whether milk is whole, low fat (1 or 2%), or skim. Include
flavoring if one is used.
5. VEGETABLES and FRUITS: One average serving of cooked or canned fruits
and vegetables is about a half cup. Fresh whole fruits and vegetables should be
listed as small, medium or large. Be sure to indicate if sugar or syrup is added to
fruit and list if any margarine, butter, cheese sauce, or cream sauce are added to
vegetables. When recording salad, list items comprising the salad separately and
be sure to include salad dressing used.
6. EGGS: Indicate method of preparation (scrambled, fried, poached, etc.) and
number eaten.
7. MEAT I POULTRY / FISH: Indicate approximate size or weight in ounces of the
serving. Be sure to include any gravy, sauce or breading added.
CHEESE:
Indicate kind, number of ounces or slices, and whether it is made from
8.
whole milk, part skim, or is low calorie.
9. CEREAL: Specify kind, whether cooked or dry, and measure in terms or cups or
ounces. Remember that consuming 8 oz. of cereal is not the same as consuming
one cup of cereal. 1 cup of cereal generally weighs about 1 ounce.
10. BREAD and ROLLS: Specify kind (whole wheat, enriched wheat, rye, etc.) and
number of slices.
11. BEVERAGES: Include every item you drink excluding water. Be sure to record
cream and sugar used in tea and coffee, whether juices are sweetened or
unsweetened and whether soft drinks are diet or regular.
12. FATS: Remember to record all butter, margarine, oil and other fats used in
cooking or on food.
13. MIXED DISHESi/ CASSEROLES: List the main ingredients and approximate
amount of each ingredient to the best of your ability.
14. ALCOHOL: Be honest. Record amounts in ounces. Specify with "light" or
"regular" beer.
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Dietary Record Form
Name: -----------Date: _______ (Please use a new copy for each day)
Food Item

Amount

Time

Express approximate measures in cups ( c), Tablespoons (T), teaspoons (t), grams (g),
ounces (oz), pieces, etc.
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Dietary Record Form

Name: -----------Date: _______ (Please use a new copy for each day)
Food Item

Amount

Time

Express approximate measures in cups (c), Tablespoons (n, teaspoons (t), grams (g),
ounces (oz), pieces, etc.
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Dietary Record Form
Name: -----------Date: _______ (Please use a new copy for each day)
Food Item

Amount

Time

Express approximate measures in cups (c), Tablespoons (T), teaspoons (t), grams (g),
ounces (oz), pieces, etc.
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